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Abstract 
The requirement to have more definitive and wider ranging body fluid identification 
(BFID) tests has resulted in a range of mRNA based real-time PCR BFI assays utilising 
Taqman fluorescent dye. An attempt to make a reliable and cost effective BFI test utilising 
the alternative SYBR Green fluorescent dye was carried out.  RNA was extracted from 
blood and saliva stains from both male and female donors, this was then reverse 
transcribed using M-MLV and random hexamers.   Using real-time PCR, relative 
quantitation of blood and saliva specific markers was carried out on the cDNA from the 
blood and saliva samples using the SYBR® Green fluorescent dye.  Melting curve analysis 
was also performed immediately following PCR amplification. The relative quantitation 
values were calculated using the formula 2-ΔΔCT and all samples were normalised to 
reference gene 18s rRNA.  The results revealed good specificity for a number of markers 
using this chemistry, however some markers were undetected.  Blood markers NCF2, 
SPTB, PBDG and saliva specific markers HTN3, SPRR1A, KRT4 and KRT13 were 
investigated.  In the SYBR green studies, the most specific markers were NCF2, KRT4, 
KRT13 and SPRR1A, showing reproducible results in a number of studies.  Blood marker 
SPTB also appeared to be specific to blood however the melt curve data for this marker in 
each study was questionable given the low melting temperature for the amplified products.  
Blood specific marker PBGD, and saliva specific marker HTN3 were not detected using 
SYBR Green and saliva marker STATH was detected however in each case appeared to be 
non-specific in nature when them melt curves were analysed.  Analysis of the 18s rRNA 
Ct values showed a higher expression in saliva than in blood in almost all instances, this 
may be due to collection of a higher number of cells when using a buccal swab, coupled 
with the inability to accurately quantify the RNA extracts before reverse transcription.  
Taqman assays were run on all markers as an additional test, to compare with the SYBR 
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green data.  All markers except SPTB showed very good specificity for their respective 
body fluids.  SPTB, like in the SYBR green studies was detected in blood more than 
saliva, however detection was never consistent in each sample.  It can therefore be said 
that real-time PCR using SYBR Green dye was capable of identifying specific mRNA 
markers blood and saliva however, the lack of specificity for this type of assay makes its 
use as a routine identification of body fluids in forensic casework not suitable.  The main 
aim of this study was to develop a more cost effective BFID and as such involved the use 
of SYBR Green as a cheaper alternative to TaqMan.  However, throughout these studies, it 
appeared to be quite costly in terms of validating a SYBR Green experiment, as more 
reagents were required in the long run due to vast amount of no template controls required 
per experiment.  It therefore would appear that while SYBR Green is cheaper to buy, the 
cost to validate these type of experiments can be quite high, due to the non-specific nature 
of the dye itself.  The SYBR Green studies were also much more time consuming with 
regards to data interpretation as post analysis of the amplification plot and melt curves is a 
necessity with this detection chemistry to ensure successful interpretation of the data. 
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1.1 Why is body fluid identification necessary 
Although DNA profiling is a powerful technique employed by forensic scientists to 
identify an individual from body fluid evidence encountered at crime scenes, it is often 
necessary in forensic casework to identify the body fluid from which the DNA was obtained 
from.  In casework, a DNA profile can be used to identify the suspect and/or victim and even 
exonerate an innocent person who has been wrongly convicted.  However, this evidence alone 
does not reveal the circumstances by which it got transferred.  For investigators, the ability to 
identify of the type of body fluid from which a DNA profile originated could provide an 
important link between the donor of the sample and how the biological material was 
transferred, this contextual information could therefore greatly increase the evidential value of 
a DNA profile.  For example, a DNA profile originating from skin cells could have a different 
meaning in a case than a profile that has originated from spermatozoa.   
 
1.2 Conventional methods of body fluid identification 
The most commonly encountered body fluids at a crime scene are blood, saliva, semen, 
vaginal secretions and menstrual blood.  Over the years a number of methods have been 
developed for the identification of body fluids in biological stains, these include chemical and 
immunological tests, protein catalytic activity tests, spectroscopic methods and microscopy 
(Kobilinsky, 2012).   These conventional methods are however subject to a number of 
limitations; the majority are presumptive in nature i.e. the can produce false positive and 
negative results, they lack specificity i.e. cross-reaction with other species or tissues, and they 
also lack sensitivity. 
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1.3 Identification of Blood 
1.3.1 Kastle-Meyer and LMG Test 
The most commonly used body fluid identification tests for blood are Kastle-Meyer 
(KM) also known as phenolphthalein and Leucomalachite Green (LMG).  The KM test relys 
on the peroxidase-like activity of haemoglobin in blood to catalyse the oxidation of 
phenolphthalein.  The peroxidase-catalysed oxidation changes the oxidation state of 
phenolphthalein, and as a result the substrate changes from colourless to a bright pink colour, 
thus indicating the possibility of blood being present.  Compared to the luminol test, an earlier 
presumptive test for blood, the reactions are based on a colour change rather than 
chemiluminescent emission (Webb et al., 2006, Counsil and McKillip, 2010).  The LMG test 
is based on the same principle as Kastle-Meyer and performed under acidic conditions, the 
oxidation reaction changes the colour of the substrate from colourless to blue/green.  The 
sensitivity of this test is similar to that of the Kastle-Meyer.  Both of these tests are prone to 
false positive results i.e. oxidative and peroxidase false positives, and are therefore said to be 
indicative rather than definitive (Cox, 1991). 
 
1.3.2 The Luminol Test 
The luminol test, has been around for over forty years (Barni et al., 2007), and used to 
be the most commonly used blood identification test, until recent years where forensic 
scientists predominantly use the LMG and KM test for the detection of blood.  This was due 
to its higher sensitivity over other presumptive screening methods.  It’s classified as a 
chemiluminescent test and like the LMG and KM test, relys on the peroxidase-like activity of 
haemoglobin in blood.  Investigators spray a suspected area with an aqueous solution of 
luminol (5-amino-2,3-dihydro-1,4-phthalazine-dione) and an oxidant, usually hydrogen 
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peroxide (H2O2), and in the presence of a catalyst i.e. peroxidase or in the case of blood stains 
haemoglobin, oxidation of luminol occurs.  This oxidation reaction changes the oxidation 
state of luminol, resulting in its electronic excitation and the emission of blue/green 
chemiluminescence (An, 2012, Webb et al., 2006, Johnston et al., 2008). Although the 
luminol test was a popular choice of presumptive test, it is not without its drawbacks.  There 
are a number of interfering substances that can catalyse the chemiluminescence of luminol as 
effectively as haemoglobin, which lead to false positive results (Barni et al., 2007, 
Quickenden and Creamer, 2001, Creamer et al., 2003, Nilsson, 2006).  These substances 
commonly occur in our everyday environment for example, disinfectants, soil, metal objects, 
plants, fruit and vegetables and domestic and industrial bleaches to name a few.  The latter of 
these substances are highly problematic to forensic investigators when interpreting the results 
of a luminol test, as perpetrators have been known to use bleach to clean up a crime scene in 
an attempt to remove any traces of blood (Quickenden and Creamer, 2001).  Grass stains are 
also commonly encountered at a crime scene.  
 
1.3.3 Fluroescein and Bluestar Forensic 
Two other chemiluminescent tests available to forensic investigators for the 
presumptive identification of blood are the fluorescein method and Bluestar® Forensic (Barni 
et al., 2007). The latter method is a luminol-based formulation, which was developed in an 
attempt to improve on traditional luminol spray (Barni et al., 2007).  Both of these tests are 
similar to the luminol test in that they rely on the peroxidase-like activity of haemoglobin, for 
example, in the presence of a peroxidase-catalyst, oxidation of fluorescin to fluorescein 
occurs in hydrogen peroxide.  Albeit as effective as the luminol test, fluorescein as a choice 
of presumptive test is still less favourable, the main reason for this being, stains that are 
sprayed with fluorescin require additional exposure to an ALS to be visualised, whereas 
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luminol does not (Garofano et al., 2006). Studies have also shown that both of these tests are 
not detrimental to potential DNA evidence (Barni et al., 2007, Garofano et al., 2006). 
 
1.3.4 Benzidine, ortho-toluidine and TMB test 
Another chemical test that relies on haemoglobin in blood is the benzidine test, which 
was originally one of the most widely used presumptive tests, when blood reacts with the 
ethanol/acetic acid solution, a deep blue precipitate is formed (Webb et al., 2006).  Like the 
majority of presumptive tests, this test lacks specificity and produced false positives, and due 
to the carcinogenic properties of benzidine, this test was discontinued.  Replacement of this 
test resulted in the development of a further two chemical based presumptive tests for blood, 
the first is the ortho-toluidine (o-toluidine) test and the second is the tetramethylbenzidine 
(TMB) test.  Both of these reagents are derivatives of benzidine, however o-toluidine was 
also largely discontinued after the discovery that this chemical, like its parent molecule 
benzidine, had carcinogenic properties and the use of TMB became more popular.  TMB 
(3,3’, 5,5’-tertramethylbenzidine) is the main reagent used in the Hemastix® test, this 
presumptive test was originally a field test designed for the identification of blood in urine but 
has since been used to detect blood stains on surfaces.  In comparison to other chemical tests, 
this method produces a higher number of false positive results and is therefore a less popular 
method of choice for forensic investigators (Virkler and Lednev, 2009). 
 
1.3.5 Takayama Test 
Blood identification is can also carried out by crystal tests, the most common test 
being the Takayama test.  When a dried blood stain is heated in the presence of pyridine and 
glucose, formation of haemochromogen occurs, resulting in needle-like crystals.  This test has 
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decreased sensitivity in comparison to other presumptive tests, but it considered to be 
confirmative for the presence of blood.  
  
1.4 Identification of Semen 
In sexual offence cases, forensic investigators are often faced with the challenge of 
identifying and recovering biological material that will link a perpetrator to the complainant.  
The ability to definitively identify semen in such cases could provide crucial probative 
evidence when reconstructing the crime.  The majority of sexual offence crimes are 
unwitnessed therefore this evidence type is often required to corroborate the alleged crime, 
which in turn could have a major impact on the outcome of a case.  
 
1.4.1 Composition of Semen 
Normal semen is comprised of two major components; seminal fluid, which is a 
mixture of fluids secreted largely by the prostate gland, seminal vesicles and Cowper’s gland, 
and spermatozoa - these are the cellular components of semen which contain the male’s 
genetic information.  The spermatozoa count in healthy males has been reported to range 
between 107 and 108 (spermatozoa/mL of semen), the average male ejaculate containing 3.5 
mL of seminal material.(Mitchell, 2012, 2012)  Abnormalities in this spermatozoa count can 
be observed in some males, for example, oligzoospermia, which is a condition where males 
have an abnormally low spermatozoa count (usually less than 20 million spermatozoa per mL 
of semen), or azoospermia, which is a medical condition characterised by zero spermatozoa in 
semen (Skinker et al., 1997).  Azoospermia can also be observed in males following a 
vasectomy, which is a surgical operation to render a male sterile or infertile; this procedure 
prevents spermatozoa from reaching the distal portions of the male reproductive tract by 
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ligating and cutting the vas deferens.  Vasectomised males and males with abnormal 
spermatozoa conditions are still able to secrete seminal fluid (Kobilinsky, 2012, Harvey, 
2010).   
Forensic identification of semen often begins with the visual examination of evidence 
utilising alternative light sources.  Once a suspected stain has been detected and located, after 
appropriate preparation, presumptive assays are then employed to indicate the presence of 
semen; these assays are based on the detection of enzymes present in seminal fluid.  The 
presence of semen is then confirmed by performing confirmatory assays, these include the 
microscopic examination of spermatozoa and immunochromatographic assays that utilise 
antibody-detecting antigens present in seminal fluid.  
There are a number of presumptive screening tests available to investigate the possible 
presence of semen.  The most popular is the presumptive test for seminal acid phosphatase 
(SAP), which has been used by investigators for a number of years (Kind, 1957, Virkler and 
Lednev, 2009)   
 
1.4.2 Seminal Acid Phosphatase Test  
The SAP test is reliant on the reported high concentrations of the water-soluble 
enzyme acid-phosphatase in seminal fluid (Lewis et al., 2013, Redhead and Brown, 2013).  
There are two types of sample collection methods for the AP test that forensic investigators 
will employ when detecting semen, depending on the type of stain encountered; these are 
direct and indirect methods.  The former direct method involves an intimate swab being 
moistened with water and rolled or transferred onto filter paper, or an extract of a possible 
semen stain will be dropped and transferred onto a filer paper.  The latter indirect method is 
used for detection of possible semen stains on larger items or surface areas, where filter paper 
8 
 
is placed over the area/item, moistened with water and pressed firmly to transfer semen onto 
the filter paper.  In both cases, a chemical reagent is applied to the filter paper, there are a 
number of variations in the chemical reagents used (Virkler and Lednev, 2009), however a 
more commonly used reagent consists of; sodium acetate, acetic acid, α -naphthyl phosphate 
disodium salt and brentamine fast black K salt (Redhead and Brown, 2013, Lewis et al., 
2013).  If acid phosphatase is present, the organic phosphatase hydrolysis of α-naphthyl to α-
naphthol will occur, which then reacts with the brentamine fast black K salt, the result is a 
colour change from orange to purple (Lewis et al., 2013, Redhead and Brown, 2013).  Over 
the years it has been routine procedure to allocate two minutes for this reaction to occur, after 
which, if no reaction has occurred the result is reported as negative.  This cut-off time 
however has recently been challenged in a study which reported two minutes was insufficient 
to detect the majority of stains.  It reported that after 15 minutes, diluted stains using both the 
direct and indirect method could still be detected (Redhead and Brown, 2013). 
Albeit the preferred choice of presumptive test for the detection of semen for 
investigators, the AP test is still not completely reliable; it produces false positives due to acid 
phosphatase being present in other biological materials such as vaginal material (Virkler and 
Lednev, 2009, Redhead and Brown, 2013).  It has also been reported that a common 
multipurpose detergent can have inhibitory effects on AP tests (Vennemann et al., 2014).  
Seminal acid phosphatase levels also vary between males, therefore detectability is reliant on 
the concentration of AP in a suspected stain (Redhead and Brown, 2013).  Due to the 
presumptive nature of the AP test, further confirmatory testing is required to confirm the 
presence of semen.  For semen containing spermatozoa, this is done microscopically and for 
cases where azoospermic semen is suspected, tests such as the Choline, Laurell Rocket 
Electrophoresis and Prostate Specific Antigen (PSA) are usually employed (Davidson and 
Jalowiecki, 2012, Redhead and Brown, 2013).     
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1.4.3 Histological staining and Microscopic Identification of Spermatozoa 
When a presumptive test provides a positive result indicating the presence of semen, 
investigators will then perform further confirmatory tests.  The most commonly used 
confirmatory test is the microscopic observation of spermatozoa cells (the cellular component 
of semen) following histological staining.  Spermatozoa have three unique and distinct 
characteristics; a DNA containing head, a midpiece, and a tail (Mitchell, 2012).  Prior to 
microscopic analysis, stains are swabbed or smeared onto microscopic slides and stained with 
one of a selection of dyes, to enable spermatozoa if present, to be visualised under the 
microscope.    
 
1.4.4 Conventional staining techniques 
One traditionally used stain is the haematoxylin-eosin stain, which dyes the DNA 
heads in spermatozoa a purple colour.  However, a more popular stain is the ‘Christmas Tree’ 
stain, reported to be more effective and reliable over haematoxylin-eosin, and was given its 
name due to its distinctive colour pattern of red and green (Allery et al., 2001, Davies and 
Wilson, 1974, Virkler and Lednev, 2009, Allard, 1997, Allard et al., 2007, Mitchell, 2012, 
Allery et al., 2003, Romero-Montoya et al., 2011).  This stain is comprised of two reagents; 
picroindigocarmine and Nuclear Fast Red (also known as Kernechtrot).  The 
picroindigocarmine reagent stains the neck and tail portions of spermatozoa a green/blue 
colour, and the Nuclear Fast Red reagent stains the DNA heads differentially, in that the head 
is stained a red colour, and the acrosomal caps (the tips of the heads) a pink colour.    Other 
stains have been used and tested for the microscopic detection of spermatozoa, such as 
Papanicolaou, Baecchi, May-Grunwald-Giemsa, Wright’s stain and acridine orange, these 
stains are however a less popular choice as they are less effective than the ‘Christmas Tree’ 
stain (Virkler and Lednev, 2009, De Moors et al., 2013). 
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1.4.5 Disadvantages of microscopic analysis 
Although microscopic analysis of spermatozoa is a confirmatory test it has a number 
of disadvantages.  Firstly, if the donor of the sperm is oligospermic i.e. the seminal stain is 
from a male with a low sperm count, or azoospermic, where the stain is from a male who 
produces no spermatozoa (either due to natural causes or a vasectomy) then little or no 
spermatozoa will be present, thus making a positive identification of semen 
difficult/impossible using microscopic analysis (Virkler and Lednev, 2009, Skinker et al., 
1997, Miller et al., 2011).  In such situations where false negative results are produced, i.e. 
when the presumptive test indicates the presence of semen, yet the microscopic analysis 
yields no detectable spermatozoa, further tests are required to determine the presence semen.  
One marker used for the identification of semen when no spermatozoa is present, is the 
glycoprotein P30, which is a prostate-specific antigen (PSA) secreted by the epithelial cells of 
the prostate gland, and is present in seminal fluid.  It is produced independently from the 
generation of spermatozoa and can therefore be used for both spermic and azoospermic 
samples.  The most common PSA test is the ABAcard® p30 test (Hadi et al., 2010, Boward 
and Wilson, 2013). 
Identification of semen may also be difficult in cases where there is little evidence 
and/or the quality is low (Wasserstrom et al., 2013).  Spermatozoa biologically degrades over 
time, the tails are susceptible to damage and usually degrade first, separating easily from the 
sperm heads after ejaculation.  The surrounding environment and the condition of the stain 
are vital factors which affect the degradation of spermatozoa (Mitchell, 2012).  Another 
disadvantage of microscopic analysis is the lack of specificity when a stain is contaminated, 
i.e. when there are high levels of epithelial cells, bacteria and cellular materials present.  The 
staining methods mentioned above are not specific to human sperm cells, and therefore 
interpretation can be difficult and extremely time-consuming (Mitchell, 2012, Miller et al., 
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2011).  Examination of the smear slides is a non-automated procedure, which must be 
performed by an experienced and skilled forensic analyst who has the ability to distinguish 
between spermatozoa and other cell types  (Miller et al., 2011, Christoffersen, 2011).  
One study however, has recently attempted to address these time-consuming issues 
and demonstrated the use of an automated microscope/detection system called the KPICS 
SpermFinder™.  The results of this study showed that the automated system, which had an 
algorithm designed to locate spermatozoa on a ‘Christmas tree’ stained microscope slide, 
located more spermatozoa than manual examination (Mitchell, 2012). 
Recently, a new stain, the SPERM HY-LITER™ kit has been developed by 
researchers in an attempt to standardise and improve the efficiency of the microscopic 
screening of semen evidence.  It is a fluorescent based assay that uses mouse monoclonal 
antibodies to specifically target human spermatozoa.  In comparison to conventional staining 
methods, this assay is reported to be more robust, and reliable, producing fewer false positive 
and negative results.  It is also offers higher specificity and sensitivity, and is a much faster 
and simpler technique (Christoffersen, 2011, De Moors et al., 2011, De Moors et al., 2013, 
Miller et al., 2011, Silva et al., 2007)  
 
1.5 Identification of Saliva 
The ability to definitively identify human saliva in forensic casework could provide 
investigators with important probative evidence when reconstructing a crime, especially in 
sexual assault cases which often involve oral activity and the deposition of saliva.  This type 
of evidence is a potential source of DNA due to the epithelial cells present in saliva, and 
could aid in corroborating a victim’s allegation by demonstrating contact between the 
complainant and the perpetrator.  For example, saliva on the skin, bite mark evidence or even 
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mixed stains of saliva and semen in the cases of oral intercourse (Breathnach and Moore, 
2013, Auvdel, 1986, Soukos et al., 2000, Silva et al., 2007). 
 
1.5.1 Composition of saliva 
Human saliva is a colourless fluid comprised of more than 99% water and <1% 
proteins and salt.  It is produced and secreted into the oral cavity mostly from three major 
salivary glands; the parotid, the submandibular, and the sublingual glands. Saliva is required 
for the process of mastication and its primary function is to aid in the initial processes of 
digestion.  A normal individual on average produces between 500ml and 1500ml of saliva a 
day, at a rate of approximately 0.5ml/minute (Old et al., 2009, Chicharro et al., 1998, 
Chiappin et al., 2007).  Human salivary α-amylase is the major protein component in human 
saliva which catalyses the initial step in the digestion of starch, a main source of 
carbohydrates in the diet (Pang and Cheung, 2008, Butterworth et al., 2011).  Amylase in 
humans is expressed by two separate genetic loci in humans on chromosome 1; AMY1, the 
salivary locus and AMY2, the pancreatic locus (Breathnach and Moore, 2013, Butterworth et 
al., 2011, Virkler and Lednev, 2009).  There is an abundance of AMY1 salivary amylase in 
saliva, and lower concentrations in breast milk and perspiration.  The AMY2 pancreatic 
amylase is found in urine, blood, semen, faeces and vaginal secretions (Breathnach and 
Moore, 2013, Virkler and Lednev, 2009, Myers and Adkins, 2008).  In comparison to all 
other body fluids, saliva has been reported to have the highest concentration of α-amylase 
(Breathnach and Moore, 2013, Kipps and Whitehead, 1975, Myers and Adkins, 2008).  
Because of this, presumptive tests for saliva were developed using amylase, however such 
tests remain preliminary, as even though saliva produces a high concentration of amylase it is 
still found in other biological fluids and can therefore not be confirmative (Nakanishi et al., 
2011, Virkler and Lednev, 2009, Nakanishi et al., 2009). 
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1.5.2 Starch-iodine Test and Phadebas® Amylase Test 
Most of the conventional methods for the identification of saliva rely on the detection 
of the activity of salivary enzyme α-amylase (Akutsu et al., 2010, Auvdel, 1986, David and 
Judy, 2010, Feia and Novroski, 2013, Hedman et al., 2011, Keating and Higgs, 1994, Kipps 
and Whitehead, 1975, Martin et al., 2006, Myers and Adkins, 2008, Olsén et al., 2011, Old et 
al., 2009, Virkler and Lednev, 2009, Breathnach and Moore, 2013, Butterworth et al., 2011, 
Pang and Cheung, 2008).  This type of presumptive test has been used for over thirty years 
(Hedman et al., 2011).  The α-amylase enzyme hydrolyses α-1-4 glycosidic liinkages in 
polysaccharides such as starch.  The most common presumptive tests for the detection of 
amylase in saliva are the starch-iodine assay or the Phadebas® amylase test.  In the starch-
iodine test, a sample is incubated in starch solution to initiate α-amylase activity.  This is then 
followed by the addition of iodine, where starch in the presence of iodine gives a 
characteristic deep blue colour.  In the presence of amylase, starch will break down and a 
positive result for amylase is indicated by the disappearance of the blue colour.  The 
Phadebas® reagent is one of the most common commercial products, it utilises a water 
insoluble starch that is covalently linked to a blue dye.  A positive result is based upon the α-
amylase activity in the suspected saliva sample hydrolysing the starch-blue dye bonds which 
lead to a release of blue dye into solution that can be quantitated (Myers and Adkins, 2008). 
In addition to the tube test a Phadebas® Forensic Press Test has also been developed to locate 
saliva stains on surfaces, in such tests the reagent is applied to filter paper which is then 
applied to the region of interest (Olsén et al., 2011). 
One of the main disadvantages of these activity-based detection methods is these tests 
cannot identify between the two types of α-amylase or between the many nonhuman sources 
of this enzyme i.e. bacterial, pancreatic, fungal or nonhuman saliva (Old et al., 2009), they 
also lack specificity and sensitivity. 
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1.5.3 RSID-Saliva and SALIgAE-Saliva 
Recently, the RSID-Saliva immunochromatographic test and a colourimetric test 
called SALIgAE-saliva have been developed and both demonstrated higher specificity and 
sensitivity over the Phadebas® test (Akutsu et al., 2010, Old et al., 2009, David and Judy, 
2010).     
 
1.6 Alternative Light Sources  
One of the simplest identification methods for blood, semen and saliva stains at a 
crime scene is the alternative light source, (ALS).  This method is a presumptive screening 
test often used to detect and locate stains at a crime scene prior to performing further 
presumptive chemical analyses.  This preliminary test is ideal for investigating large forensic 
areas for stains that are not visible to the naked eye, providing a more specific location for 
collection, rather than testing large areas unnecessarily. Once a stain has been located using 
this simple and non-destructive method, photographs of the enhanced stain can be taken and 
further tests are then usually performed to determine the presence of a body fluid. 
 
1.6.1 Blood 
The most common light source used for the detection of blood is the Polilight® which 
produces intense bands of light at wavelengths between 310 and 650 nm (Vandenberg and 
Oorschot, 2006), blood is said to have a strong absorption band around ~ 415 nm (Stoilovic, 
1991).  The main disadvantages of this test however, are the lack in specificity and 
sensitivity, one study showed the maximum detectable dilution of blood stains using a 
Polilight® was 1/1000, in comparison to a chemical based method such as luminol which 
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showed a higher degree of sensitivity upto 1/5000000 (Webb et al., 2006, Vandenberg and 
Oorschot, 2006, Jackson and Hadi, 2007). 
 
1.6.2 Semen 
There are a number of commercial light sources available to forensic investigators, 
these include the Woods Lamp, Bluemaxx™ BM500 and the Polilight® (Virkler and Lednev, 
2009, Vandenberg and Oorschot, 2006, Stoilovic, 1991)  
The Wood’s Lamp (WL) emits light in wavelengths between 320 and 400nm (Gupta 
and Singhi, 2004), this light source has been used over a number of years for the detection of 
semen at crime scenes, however studies have since reported on its lack of sensitivity and 
specificity (Santucci et al., 1999).  The WL is unable to differentiate between semen and other 
commonly found substances producing false positive results, and it has recently been reported 
that at 360 nm wavelength semen does not fluoresce using the WL (Nelson and Santucci, 
2002, Virkler and Lednev, 2009).  The Bluemaxx™ BM500 is another commercial light 
source that emits light in wavelengths between 390 and 500 nm and offers greater sensitivity 
and specificity over the WL (Virkler and Lednev, 2009).  Another common yet more 
expensive light source is the Polilight®, which emits light in wavelengths between 415 and 
650 nm, this light source offers greater specificity over other light sources, as it emits 
wavelengths in a narrow band (Wawryk and Odell, 2005).  One study reported that the 
sensitivity of the Polilight® was comparable to the chemical presumptive test acid 
phosphatase test (AP) (Vandenberg and Oorschot, 2006).   One of the main drawbacks to this 
light source is its lack of portability due to its size, making field testing more 
difficult.(Wawryk and Odell, 2005). 
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1.6.3 Saliva 
 Alternative light sources are also used to detect saliva stains, when viewed under UV 
light, saliva appears a light blue colour.  Commercial light source Polilight® has been reported 
for use in detection of saliva stains (Vandenberg and Oorschot, 2006) 
 
1.7 Identification of Vaginal Material 
Vaginal material is not as commonly encountered at crime scenes like blood, saliva 
and semen, however when this evidence is available the ability to identify such stains could 
play an important role in sexual assault cases.  Vaginal material can be found in the 
underwear of rape victims, penile swabs, condoms and other objects that may be used in a 
sexual assault.  Vaginal secretions are a complex fluid and contain a large amount of 
epithelial cells, very similar to buccal cells.  The ability to distinguish between buccal cells 
and vaginal epithelial cells could provide important probative evidence.  For example a 
perpetrator could claim buccal cells are present due to oral activity i.e. drinking from a bottle; 
whereas the victim’s allegation could differ dramatically claiming the buccal cells present on 
the bottle are a result from penetration in a sexual assault.   
 
1.7.1 Lugol’s Iodine Method 
There are currently no reliable tests for the identification of vaginal material; one 
proposed test was the Lugol’s Iodine Test, which was based on the detection of glycogen in 
vaginal material (Hausmann et al., 1994, Rothwell and Harvey, 1978).  This method proved 
to be highly susceptible to false positives and lacked specificity for vaginal material, and as 
such was reported too unreliable for use in forensic casework.   
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1.8 Sensitivity and Specificity of current presumptive tests 
In the current literature, differing sensitivities and specificities are reported for the 
various presumptive blood tests.  A recent study by (Vennemann et al., 2014) investigated 
both the KM and LMG test, and reported that the KM test was higher in both sensitivity and 
specificity compared to LMG.  Dilution factors in this study ranged from 10-1 to 10-7, both 
tests showed a positive result for each dilution factor.  However, 100 % positive results, 
which in this study was 57/57 tests, were only reported up to 10-2 for LMG and up to 10-3 for 
KM, this percentage decreased for each test with each further dilution.  
 In the same study, the influence of ascorbic acid, hypochlorite and ferrous sulphate 
on both the KM and LMG tests were investigated.  The addition of ascorbic acid, which is an 
anti-oxidizing reagent commonly found in fruits, vegetables or juices, caused both 
presumptive blood tests to fail and as such, this reagent was reported as a strong inhibitor for 
both tests, with the LMG test being more affected over KM.  The addition of hypochlorite 
also had an inhibitory effect on both tests and it was reported that the LMG test was more 
prone to false positive reactions compared with KM.  Hypochlorite is a strong oxidizing 
reagent known to produce false positives in presumptive blood tests.  It is a component found 
in many household cleaning agents and washing powders, and the effects of this reagent 
should therefore be considered very carefully when interpreting presumptive blood test results 
from swabs collected from bathroom or kitchen surfaces and from fabrics and clothes, all of 
which may have been subjected to hypochlorite ions.  False positive results were also 
reported for both tests with the addition of 10% ferrous sulphate solution in the absence of 
blood, with a higher percentage of false positives observed in the KM test compared with 
LMG.   Ferrous sulphate is a metal salt commonly found in sinks, showers and baths due to 
old eroding pipes, a false positive reaction for swabs taken in or around these areas could lead 
18 
 
to misinterpretation of the results and as such all or any presumptive blood test results would 
require careful consideration in a forensic investigation. 
An earlier study by (Tobe et al., 2007) also investigated the sensitivity and specificity 
of six presumptive tests for blood; three of which were the most commonly employed tests by 
police and forensic scientists throughout the world; luminol, KM, and LMG, and three newer 
tests/reagents; Hemastix®, Hemident™ and Bluestar©.  The authors of this particular study 
had written about the contradictory findings reported in previous literature on the sensitivity 
of the luminol, KM and LMG tests, where luminol dilution factors ranged from 5.0 x 10-3 to 
10-8, LMG from 5.0 x 10-3 to 10-5 and KM from 5.0 x 10-4 to 10-7, and as a result based their 
study on testing and determining the sensitivity and specificity limits of newer tests/reagents 
in comparison to the older traditional tests.  The specificity was investigated and compared by 
subjecting each new and old test to substances that are commonly known to interfere with the 
traditional reagents, or that are often misconstrued in blood spatter analysis (Table 1) and the 
sensitivity was investigated by subjecting each test to five different dilution factors (Table 2).  
The findings showed that the LMG test had a sensitivity of 10-4, whereas the remaining tests 
were able to detect blood to a dilution factor of 10-5, these results contradicted those reported 
by (Vennemann et al., 2014), where blood was detected at a dilution factor of 10-7 for both 
the LMG and KM tests.  With regards to the specificity of the six presumptive blood tests, 
each test produced a false positive for more than one common household substance.  Luminol 
was reported to be the most specific test, however the author explained that this was a 
contradictory result compared with other previous literatures, and reported that the possible 
reason for this was most probably due to the substances drying time of 18hr minimum before 
testing.  The high numbers of false positives reported in this study demonstrates that results 
from presumptive blood tests can be easily misinterpreted due to common household items.    
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Table 1: Substances investigated for false positive reactions in six presumptive blood tests, N represents no reaction and Y 
represents a positive reaction (Tobe et al., 2007) 
 
 Presumptive blood test 
Substance Luminol LMG KM  Hemastix Hemident Bluestar 
Saliva N N N Y N N 
Semen N N Y N Y N 
Potato N Y Y Y N Y 
Tomato N N N Y N Y 
Tomato 
Sauce 
N N Y N N N 
Tomato 
Sauce with 
meat 
N N N Y N Y 
Red Onion N Y Y Y Y Y 
Red Kidney 
Bean 
N N Y N N Y 
Horseradish N N Y N N Y 
0.1M 
Abscorbic 
Acid 
N N Y N Y N 
5 % Bleach N N Y N Y Y 
10% Cupric 
Sulfate 
Y Y Y Y Y Y 
10% Ferric 
Sulfate 
Y Y Y Y Y Y 
10% Nickel 
Chloride 
Y Y Y Y Y N 
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Table 2: The reported sensitivity of six presumptive tests for blood with dilution factors ranging from 10-4 to 10-7, where N 
represents no reaction observed and Y represents a positive reaction (Tobe et al., 2007) 
 
 Dilution Factor 
Test 1.E-04 1.E-05 1.E-06 2.E-07 1.E-07 
Luminol Y Y N N N 
LMG Y N N N N 
KM Y Y N N N 
Hemastix Y Y N N N 
Hemident Y Y N N N 
Bluestar Y Y N N N 
 
 Another recent study by Petersen et al (2014), investigated the specificity of 
phenolphthalein (the reagent used in the KM test) for false positive reactions from legume 
root nodules.  The nodules of leguminous plants contain a protein called leghemoglobin, 
which has a similar function and structure to haemoglobin.  The nodules of six common 
legume types including pea, bean, red clover, white clover, soyabean and alfalfa were all 
tested, along with five common garden fruits; strawberry, watermelon, tomato, blackberry 
and raspberry.  Each fruit or legume nodule was crushed to create a reddish bloodstain like 
red-brown stain and subjected to the KM presumptive blood test.  The common fruits or 
berries produced negative phenolphthalein reactions.  The crushed nodules however from all 
tested legume plants yielded phenolphthalein false-positive reactions, all of which were 
reported to be indistinguishable from true bloodstains both in colour quality and in the time it 
took for the colour to develop.  In this study, leguminous nodules were also crushed onto 
clothing and other material, air dried and then frozen.  Each stain yielded a false-positive 
reaction for phenolphthalein after four years.  The bloodlike staining caused by 
leghemoglobin-containing nodules when crushed, combined with the false-positive reactions 
for phenolphthalein, even several years after exposure on some materials or clothing, shows 
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there is potential to mislead investigators with regards to the origin of DNA profiles obtained 
from stained evidentiary items. 
   Vennemann et al, 2014 also studied the specificity of the acid phosphatise test.  The 
study involved the analysis of a variety of teas for false positive reactions, camellia sinenus 
teas both the darjeeling and assamica (green and black) produced false positives for AP, as 
did two garden plants; c japonica camellia and erica heather.  A common multipurpose 
detergent known as Teepol was also shown to be inhibitory to the AP test.  
Another study that investigated the specificity and sensitivity of a direct and indirect 
(aerosol) acid phosphatise test was (Lewis et al, 2013), direct AP testing was reported to be of 
a higher sensitivity than the indirect, and each test subjected to a number of household 
products to check for specificity too, these ranged from green beans, broccoli, horseradish, 
laundry soap to lemon juice.  In total there were 22 common household products listed.  AP 
tested positive for a number of products in this study, the direct test showing quicker 
reactions to false positives than the indirect.   The results from this study show that the AP 
test can like other presumptive tests provide a large number of false positives for many 
commonly found substances which can mislead investigators in casework. 
For saliva, a study by (Casey and Price, 2010) investigated the sensitivity of the 
RSID™- saliva test and the phadebas test, the results showed that the RSID test had a greater 
sensitivity than that of the Phadebas, it also has no cross over with other human forensicfally 
relevant body fluids.  The Phadebas test has been reported to have a sensitivity of 1:100 when 
the sample was incubated at room temperature and 1:200 at 37°C (Hedman et al, 2008) 
Real-time PCR in comparison to these conventional methods is a much more sensitive 
technique with sensitivities down to pg measurements, the limit of detection being the defined 
as the lowest amount of target that was amplified, real-time PCR offers much more sensitivity 
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given that it is able to analyse amplification in real time.  If mRNAs are present and detected 
at such low values this offers much greater sensitivity over current methodologies. 
 
1.8 mRNA body fluid identification methods 
Based on current the methodologies, it is clear there is a requirement for a more 
definitive body fluid identification (BFID) test.  Conventional methods for all their 
advantages are prone to quite a number of false positive reactions, which could potentially 
mislead a forensic investigator when dealing with evidentiary items, they are also performed 
separately to DNA analysis, which can be problematic when there is limited sample available 
for the investigator to use – small stains sizes are common in forensic casework.  An ideal 
BFID test therefore, would be one that identifies the origin of a DNA profile in the same 
assay, for example, a genetic test that will coincide with DNA profiling.  Messenger RNA 
could be play a vital role in such a genetic test.  The central dogma states that genetic 
expression starts with the DNA, which is transcribed into mRNA and subsequently translated 
into proteins.  Proteins are present in all biological material, some of which will be specific to 
a particular body fluid and as such it is these proteins that will enable us to specifically 
identify body fluid types.  Isolation and thus identification of the specific mRNAs that are 
responsible for the production of a particular protein in certain body fluids could play a vital 
role in the development of a mRNA body fluid identification test for use in forensic 
casework. 
In recent years, RNA profiling has been adopted and proposed as a supplement to 
conventional BFID tests.  RNA was once thought to be too unstable to use in forensic 
analysis, hence the major advances in DNA analysis over the past few decades.  A number of 
recent studies however have contradicted the inherent instability of RNA, showing that in 
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actual fact RNA isn’t quite as unstable as what was originally thought (Vennemann and 
Koppelkamm, 2010, Kohlmeier and Schneider, 2012, Juusola and Ballantyne, 2003, Setzer et 
al., 2008).  This breakthrough has encouraged researchers worldwide to delve in to the world 
of RNA and explore its possible uses in the identification of body fluids.  The RNA profiling 
methods employed in the literature over the past decade are based on the analysis of 
forensically relevant tissue-specific genes, and at the start of this study, the majority of 
methods focused on messenger RNA (mRNA) gene expression analysis.   
One study by (Juusola and Ballantyne, 2003) reported the basis of a prototype RNA 
based assay that could later be developed as a supplement to conventional BFID methods.  In 
this study, mRNA from housekeeping genes S15, β-actin and GAPDH was detected in blood 
semen and saliva stains.  This method employed the use of reverse transcriptase-polymerase 
chain reaction (RT-PCR).  A number of potential saliva-specific genes were also reported to 
be detected in this study, these included statherin (STATH), histatin 3 (HTN3) and PRB1, 
PRB2 and PRB3, mRNA from each of these genes were detectable in saliva but not blood or 
semen. 
Another study around that time by (Bauer and Patzelt, 2003a) proposed a method for 
simultaneous RNA and DNA isolation from dried blood and semen stains.  It is understood 
that DNA analysis takes precedence in routine forensic laboratory work when dealing with a 
limited sample amount, and Bauer and Patzelt therefore suggested a technique that would 
isolate RNA and DNA from the same sample, thus being able to identify to origin of the 
DNA profile.  Bauer reported that in previous literature tissue-specific mRNAs had been used 
to determine the origin of forensic stains by reverse transcription polymerase chain reaction 
(RT-PCR) and as such used mRNA in this study (Bauer and Patzelt, 2003b, Bauer and 
Patzelt, 2002).  The results demonstrated a co-isolation technique was possible when the 
sample size does not allow separate RNA and DNA isolation, and they were able to analyse 
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both the tissue-specific gene expression and the genetic profile of the same donor.  However, 
a decreased sensitivity was observed for this co-isolation method compared with direct DNA 
isolation. Therefore in cases where maximum sensitivity was required i.e. due to a very small 
amount of sample or the age of a stain, direct DNA isolation should be the method of choice 
to achieve the best possible results.  A number of mRNA and DNA co-isolation techniques 
have been described over recent years, (Alvarez et al., 2004, Haas et al., 2011c, Haas et al., 
2014, Haas et al., 2013, Watanabe et al., 2014).  Alvarez reported an optimised method, 
which included a number of body fluids, including blood, saliva, semen, and semen free 
vaginal secretions.  This was again done using RT-PCR and the results were analysed using 
gel electrophoresis, this optimised method showed greater sensitivity and robustness.  
(Bowden et al., 2011) describes another mRNA and DNA co-extraction method using the 
Promega DNA IQ™ system.   Semen, blood, saliva, vaginal fluid and menstrual blood were 
analysed in this study utilising the following mRNA specific genes; blood GlucoA, menstrual 
blood MMP11, saliva HTN3 and STATH, semen PRM2 and TGM4 and vaginal fluids CRIS 
and GASS.  Two successful methods were demonstrated in this study, Bowden et al 
developed a method that recovered mRNA from a previously discarded by-product of the 
DNA IQ™ reaction and potential mRNA profiles were developed from all casework samples 
extracted using both a manual and automated DNA IQ™ method.  There was no impact on 
the DNA extraction process using the DNA IQ™ as the DNA and RNA were separated into 
two components during the extraction process.   
From 2011 to 2014 the European DNA profiling group EDNAP performed a number 
of collaborative exercises on mRNA profiling for the identification of body fluids all of 
which employed reverse transcription, endpoint PCR and capillary electrophoresis and in the 
later studies, multiplexing was also employed. The first study (Haas et al., 2011a) involved 
the detection of blood-specific genes HBB, SPTB and PBGD in blood stains.  The results 
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showed that HBB was the most abundantly expressed gene followed by SPTB and PBGD.  
All but one out of 16 laboratories were able to isolate and detect RNA in dried bloodstains.  
This study, due to its high reproducibility and sensitivity, demonstrated the potential of 
mRNA profiling in forensic casework with regards to supplementing or even being an 
alternative to current serological methods.  The subsequent EDNAP exercises were all based 
on the co-isolation of RNA and DNA; in 2012 a second collaboration reported a reproducible 
co-isolation of RNA and DNA in bloodstains (Haas et al., 2012), this was followed by a third 
study in 2013 which involved the evaluation of mRNA markers for saliva and semen (Haas et 
al., 2013) and subsequent to this in 2014, a study investigating dried menstrual blood and 
vaginal secretions was reported (Haas et al., 2014).  Each of these studies gave a positive 
outcome with regards to supporting RNA profiling as a reliable body fluid identification 
method and one that can be easily combined with STR typing technology.   
The EDNAP exercises along with a large number of other studies are the most recent 
developments in RNA profiling, at the time of this study there were a number of studies in the 
literature on mRNA profiling.  Various body fluids were reported to be investigated 
including, blood semen, saliva, vaginal mucosa, semen, and menstrual blood.  In 2005, a 
multiplex mRNA profiling study by (Juusola and Ballantyne, 2005) investigated a number of 
tissue-specific markers for various body fluids, including HTN3 and STATH (saliva) and 
SPTB and PBGD (blood), PRM1 and PRM2 (semen) HBD-1 and MUC4 for vaginal 
secretions.  This method used again involved RT-PCR (end-point PCR) and capillary 
electrophoresis, In subsequent years a number of multiplexing/singleplez RT-PCR using end 
point PCR methods have also been described  (Haas et al., 2008, Cossu et al., 2009, Haas et 
al., 2009b, Richard et al., 2012, Fox et al., 2014, Roeder and Haas, 2013, Lindenbergh et al., 
2013).  In 2008 and 2009, a whole genome amplification technique was described by 
(Zubakov et al., 2008, Zubakov et al., 2009) used to identify stable RNA markers for the 
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identification of blood and saliva, these included saliva-specific markers SPRR1A, KRT4 and 
KRT13 and NCF2 markers for blood.  In 2013, a multiplex high resolution melting mRNA 
profiling assay was also described (Hanson and Ballantyne, 2013b). 
In 2006, (Nussbaumer et al., 2006) reported a mRNA profiling method that employed 
real-time PCR, the body fluids tested were blood, semen, vaginal fluid and saliva and Taqman 
probes were employed.  This paper demonstrated the usefulness of real-time PCR assays for 
identifying the origin of a biological stains, due to its stability and sensitivity; RNA profiling 
of various body fluids were shown to be possible, even on samples stored at ambient 
temperatures for a long period of time.  Another study that year also employed the used of 
real-time PCR (Fang et al., 2006), again Taqman gene expression assays were used and 
specific assays targeting mRNA in saliva, semen, vaginal secretions and blood were 
identified.  A number of studies subsequent to this reported the use of multiplexing and real-
time PCR utilising Taqman probes (Ballantyne and Juusola, 2007b, Patel and Peel, 2008, 
Fleming and Harbison, 2009, Sakurada et al., 2009, Haas et al., 2009a, Lindenbergh et al., 
2012, Park et al., 2013, Hanson and Ballantyne, 2013b, Xu et al., 2014). 
Since the start and throughout this study there has been a vast increase in the level of 
interest and the amount of research undertaken on the identification of body fluids utilising 
mRNA.  From 2011 onwards there were a vast number of papers published investigating 
forensically relevant body fluids, with the identification of skin becoming a popular area of 
research in BFI studies (Sakurada et al., 2011a, Gomes et al., 2011, Hanson et al., 2011, 
Visser et al., 2011, Parker et al., 2011, HadŽić et al., 2011, Wobst et al., 2011, Haas et al., 
2011b, Hanson et al., 2012, van den Berge et al., 2014, Gomes et al., 2013).  One particular 
study also investigated the identification of nasal blood and compared the expression levels of 
target genes specific to saliva, nasal secretions and blood; including menstrual blood 
(Sakurada et al., 2012), nasal blood is suggested to be one of the most difficult types of blood 
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to identify.  The results of this study showed that real-time PCR was used and able to detect 
nasal blood, however the stability of gene expression in nasal blood stains decreased over 
time, a disadvantage for older evidentiary stains in forensic casework.   
In 2013 and 2014, there were a number of studies which focused on vaginal material 
and menstrual blood (Hanson and Ballantyne, 2013a, Jakubowska et al., 2014, Jakubowska et 
al., 2013), and the most recent study to-date in the world of mRNA profiling is a study by 
(Akutsu et al., 2015) which investigates the suitability of two common extraction methods for 
RNA profiling; silica column-based membranes and automated magnetic bead extraction, this 
study was done using RT-PCR  The results of this study suggest an automated system could 
be more effective over manual extraction, the sensitivity was reported to higher in the 
automated method. 
 Based on previous literature, it can be seen that real-time PCR is a very sensitive 
technique for the detection and quantification of nucleic acids and a vital tool in the 
development and progression of mRNA profiling in forensic casework, many research groups 
have employed the use of this method.   However, at the time of this study, the majority of 
research being undertaken involved RT-PCR and analysis of the products either via capillary 
or gel electrophoresis.  Real-time PCR studies were also underway around that time in a 
number of research groups, however these studies all employed Taqman chemistry.  Assays 
utilising TaqMan chemistry are considered a costly method of analysis, an ideal mRNA BFID 
test that can be used in practice by forensic scientists would ideally be cost-effective to 
warrant the use of such a test in forensic casework.  With this in mind, SYBR Green 
chemistry, an alternative to Taqman was considered. 
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1.9 Aims 
Previous literature has outlined a requirement for a more definitive body fluid test, 
researchers worldwide are investigating the expression of mRNA specific genes in body 
fluids so that the origin of a DNA stain can be identified in forensic casework.  At the time of 
this study, it was noted that researchers employing real-time PCR for mRNA profiling were 
utilising Taqman chemistry.   
Taqman assays are the preferred choice of assay by many researchers in previous 
literature, most probably due to their specific nature and complex design.  However, these 
type of assays are very costly and it was suggested that, to establish an mRNA profiling test 
that can be routinely used in forensic casework, a more cost effective test may be required.   
The purpose of this study therefore was to find an alternative to Taqman assays to 
minimise the cost of an mRNA BFID.  This was done by utilising real-time PCR with SYBR 
Green chemistry and unlabelled PCR primers.  SYBR green lacks specificity compared to 
Taqman, it will bind to any double stranded DNA, however it was thought that it may be 
possible to validate such a chemistry and utilise melting curve analysis to positively identify 
mRNA specific genes in body fluids.   
A number of tissue-specific genes for blood and saliva were investigated in this study, 
they were adopted from previous literatures. At the time of this study    (Zubakov et al., 2008, 
Zubakov et al., 2009) reported  the identification of mRNA specific genes in blood and saliva 
stains up to 16 years and 6 years respectively.  These reports therefore proposed the use of 
such markers in forensic casework due to their reported stability and sensitivity.  As such, 
saliva-specific markers SPRR1A, KRT4 and KRT13 were used in this study, along with the 
blood specific marker NCF2.  Blood-specific markers SPTB and PBGD along with saliva 
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specific markers STATH and HTN3 were also used in this study, all these markers having 
been reported in a number of forensic mRNA analysis studies and showed good specificity in 
each study.. (Kohlmeier and Schneider, 2011, Haas et al., 2011c, Ballantyne and Juusola, 
2007a, Juusola and Ballantyne, 2005, Sakurada et al., 2009, Richard et al., 2012, Juusola and 
Ballantyne, 2003, Haas et al., 2008, Fleming and Harbison, 2009, Sakurada et al., 2011b).  
Table 3 shows a list of the mRNA specific genes investigated in this study and their 
description. 
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Table 3: Body fluid specific markers; symbol, name and description 
 
Body Fluid Gene Gene Name Description  
Blood NCF2 Neutrophil 
Cytosolic Factor 2 
Encodes p67(phox), an essential component of the 
multi-protein NADPH oxidase complex in 
phagocytic leukocytes (Gauss et al., 2006, 
Zubakov et al., 2009, Zubakov et al., 2008) 
 SPTB Beta-spectrin A subunit of the major protein component of the 
erythrocyte membrane skeleton (Chu et al., 1994, 
Amin et al., 1993) 
 PBDG Porphobilinogen  
deaminase 
An erythrocyte-specific isoenzyme of the heme 
biosynthesis pathway (Gubin and Miller, 2001) 
Saliva KRT4 Keratin 4 Type II cytokeratin expressed in differentiated 
layers of the mucosal and esophageal epithelia 
(Viaene and Baert, 1994, Zubakov et al., 2009, 
Zubakov et al., 2008) 
 HTN3 Histatin 3 Histidine-rich protein involved in the nonimmune 
host defence in the oral cavity (Sabatini et al., 
1993) 
 KRT13 Keratin 13 Type I cytokeratin expressed in the differentiated 
layers of the mucosal and esophageal epithelia – 
pairs with KRT4 protein (Viaene and Baert, 1994, 
Zubakov et al., 2009, Zubakov et al., 2008) 
 STATH Statherin Inhibitor of the precipitation of calcium phosphate 
salts in the oral cavity (Sabatini et al., 1990) 
 SPRR1A Small proline-rich 
protein 1A 
Proline-rich salivary protein (Zubakov et al., 2009, 
Zubakov et al., 2008) 
Reference  
gene 
18s rRNA  Ribosomal gene family, the structural RNA for the 
small ribosomal subunit in eukaryotic cytoplasmic 
ribosomes 
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Materials and Methods 
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2.1 Materials 
Absolute ethanol solution, ethylene oxide sterile wooden swabs with cotton tips 
supplied in a tube and sterile disposable scalpels were purchased from Fisher Scientific UK 
Ltd, Loughborough, UK.  Unistik® 3 Comfort lancet needles were from The Medical Shop, 
Owen Mumford Ltd, Oxfordshire, UK.  Silverline disposable facemasks were from Toolbay 
Direct Ltd, Yorkshire, UK.  Disposable nitrile exam gloves were from TopMedic.  MicroSol 
3+ Decontaminant Spray was purchased from Anachem Ltd, Bedfordshire, UK.  All blood 
and saliva samples were donated by myself and/or other fellow colleagues working in the 
Forensic Genetics Laboratory, School of Applied Sciences Department, University of 
Huddersfield, UK.  TURBO DNA-free™ Kit, DEPC-Treated Water, RNase-free Microfuge 
Tubes, PCR tubes and RNaseZap® RNase Decontamination Solution were purchased from 
Ambion® Invitrogen™ Life Technologies Ltd, Paisley, UK.  Eppendorf™ epReference™ 
Pipetters and epDualfilter T.I.P.S® were purchased from VWR International Ltd, 
Leicestershire, UK.  The RNeasy® Mini Kit was from Qiagen, Crawley, UK.  
BioPerformance Certified sterile-filtered water was purchased from Sigma-Aldrich Company 
Ltd, Dorset, UK.  The M-MLV Reverse Transcriptase and 10X First Strand Synthesis Buffer            
, Random Hexamers and RNase Inhibitor (Cloned) 40 U/l were all purchased from Ambion® 
Invitrogen™ Life Technologies, Paisley, UK.  The 10 mM dNTP mix was from Promega UK, 
Southampton, UK.  All unlabelled PCR primers were purchased from Eurofins MWG 
Operon, Ebersberg, Germany.  Fast SYBR® Green Master Mix, 2x TaqMan® Fast Universal 
PCR Master Mix - no AmpErase® UNG, TaqMan® Gene Expression Assays, Total RNA 
Control (Human), Eukaryotic 18s rRNA Endogenous Control (FAM™/MGB probe, non-
primer limited) and MicroAmp® Fast Optical 96-Well Reaction Plate 0.1 mL were all 
purchased from Applied Biosystems® Life Technologies, Paisley, UK. 
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2.2 Sample Collection 
Blood and saliva samples were collected from two healthy volunteers (male and 
female) under informed consent before their inclusion in this study.  The number of 
volunteers was low due to the time constraints of the project with regards to seeking the 
correct approval to expand the sample set.  One individual provided two samples; a blood and 
saliva, two individuals were assigned on one plate depending on the number of markers being 
tested, and each sample was replicated three times.   
All samples were collected in a separate room to the laboratory.  Fresh blood was 
obtained using lancet needles to prick the finger of the individual (the needles gauge were 
28G and the average blood volume for this type of needle was 5l – 30l), the blood was then 
spotted onto sterile filter paper to produce a blood stain.  After staining, the filter paper was 
then sealed in an air tight bag in preparation for RNA extraction.  Fresh saliva samples were 
collected in the form of sterile buccal swabs; this involved the volunteer swabbing the inside 
of their cheek several times to collect epithelial cells onto the cotton swab, the swab was then 
immediately placed back inside the supplied tube.  All samples were extracted immediately 
after collection. 
 
2.3 Sample Preparation 
All working surfaces and instruments/equipment were wiped clean with Microsol 
decontamination solution and then sprayed with RNaseZap, to prevent/limit the possibility of 
any contamination and to destroy any RNases present in the laboratory.  Note deep cleans 
were performed on a weekly basis in the laboratory.  As standard procedure, gowning up in a 
separate room prior to entering the laboratory took place, again to limit any contamination; 
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facemasks, gloves and howie lab coats were worn each time, gloves and masks were replaced 
out of the laboratory regularly and when necessary. 
Saliva samples were prepared by removing the buccal swab from its tube and using a 
scalpel to remove the cotton tip, the saliva stained tip was then placed in a 1.5 ml microfuge 
tube and the lid sealed immediately.  The scalpel, wooden shaft and tube were then disposed 
of immediately. Blood samples were prepared by cutting with a scalpel, three equal size small 
squares of filter paper stained with blood and placing them in a 1.5 ml microfuge; the lid was 
sealed immediately.  The scalpel and filter paper were disposed of immediately.  Note one 
scalpel was used per sample to prevent cross-contamination between samples and the 2ml 
microfuge tubes were supplied with the RNA isolation kit.  
 
2.4 RNA Isolation 
The RNeasy® Mini Kit (Qiagen, Crawley, UK) was used to isolate total RNA from all 
samples.  All solutions were made up to the manufacturer’s specification and all consumables 
were supplied with the kit, with the exception of absolute ethanol, which was sourced from 
Fisher Scientific Ltd, Loughborough, UK.      
Due to the forensic nature of the samples in this study, i.e. small sample sizes thus a 
limited number of cells, the protocol: Purification of Total RNA from Animal Cells using Spin 
Technology, was modified according to a method described by Zubakov et al. (2008), which 
involved a 1 hour incubation period at 4°C in RLT buffer solution prior to extraction.  It was 
important to mimic the low amount of sample that could be realistically recovered from a 
crime scene, in order to establish if experiments could be accomplished and results obtained 
from such a low sample size.   
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All samples were added to the 1.5 ml microfuge tubes (as previously mentioned), then 
according to the modifications described by Zubakov et al. (2008), 350 l of RLT buffer was 
added to each sample, and these were then briefly vortexed and incubated at 4°C for one 
hour.  After this incubation period, the samples were removed to the bench top and the 
protocol was then followed from step 4.  Note that when the samples were removed to the 
bench top, it was observed that the cotton tips had absorbed and retained a large amount of 
RLT buffer solution, resulting in a lower amount of lysate in the collection tube compared to 
the blood samples.  This was overcome by pressing the cotton tips with the pipette to aid the 
release of more lysate from the swab into the tube.  350 l of 70% ethanol was added to each 
sample, the ethanol solution was prepared parallel to each experiment using absolute ethanol 
(Fisher Scientific, Loughborough, UK) and nuclease-free water (Sigma-Aldrich Company 
Ltd, Dorset, UK), each sample was then mixed well by pipetting.  700 l of each sample was 
transferred to an RNeasy spin column placed in a 2 ml collection tube (supplied with the kit), 
the tubes were centrifuged at 10,000 x g for 15 s.  After centrifugation, the flow-through 
solutions were carefully discarded and the collection tubes were then re-used in the next step.  
700 l of the washing buffer RW1 (supplied with the kit), was then added to each spin 
column, to wash the silica-membranes.  The tubes were centrifuged at 10,000 x g for 15 s.  
After centrifugation, the flow-through solutions were discarded from the 2 ml collection 
tubes, and again the tubes were reused in the next step.  500 l of washing buffer RPE 
(supplied with the kit), was then added to each spin column, again to wash the silica-
membranes.  The tubes were then centrifuged at 10,000 x g for 15 s.  After centrifugation, the 
flow-through was carefully discarded again and the collection tubes were reused in the next 
step.  Another 500 l of washing buffer RPE was added to each spin column.  The tubes were 
then centrifuged at 10,000 x g for 2 minutes; this long centrifugation step dried the silica-
membranes, ensuring there was no carryover of ethanol in the next step.  The flow-through 
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solutions were carefully discarded again, and the 2 ml collection tubes were this time 
disposed of.  The spin columns were then transferred to clean 2 ml tubes and centrifuged at 
full speed for 1 minute.  This step was to eliminate any possible carryover of the washing 
buffer RPE, or any residual flow-through that remained on the outside of the spin columns 
after the last washing step.  The collection tubes, including any flow-through were discarded 
and the spin columns were transferred to a clean 1.5 ml microfuge tube (supplied with the 
kit), and 50 l of RNase-free water was then added directly to the centre of each spin column 
silica-membrane.  The spin columns were centrifuged at 10,000 x g for 1 minute, the RNA 
eluted and the spin columns were discarded.  A NanoVue™ Plus Spectrophotometer was used 
to determine the purity and concentration of the RNA samples (Section 2.5).  All RNA 
samples were either used immediately or stored at -20°C. 
 
2.5 DNase digestion of RNA extracts 
Each RNA extract was subjected to a DNase digestion treatment to remove any 
unwanted contaminating DNA using the TURBO DNA-free™ Kit (Ambion® Life 
Technologies Ltd, Paisley, UK).  A 0.1 volume of 10X TURBO DNase Buffer and 1 l of 
TURBO DNase was added to the RNA extract and mixed gently.  The extract was then 
incubated at 37°C for 30 minutes on a heat block.  After incubation, a 0.1 volume of 
resuspended DNase Inactivation Reagent was then added to the extract and mixed well.  The 
extract was then incubated for 5 minutes at room temperature and mixed occasionally by 
flicking the tubes to redisperse the inactivation reagent.  A low room temperature could affect 
the inactivation of the TURBO DNase, thus leaving residual DNase in the RNA extract.  
Therefore the room temperature was monitored throughout this incubation step to ensure the 
temperature did not fall below 22 – 26°C.  After incubation, the RNA extract was then 
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centrifuged at 10,000 x g for 1.5 minutes, forming a pellet of DNase Inactivation Reagent.  
The supernatant containing the RNA was then carefully transferred into a fresh 0.5 ml 
microfuge tube.  Careful measures were taken to ensure the inactivation reagent pellet was 
not mixed or transferred with the supernatant, as this reagent sequesters divalent cations and 
changes buffer conditions, and could thus affect any downstream enzymatic reactions.  The 
DNase digested RNA extracts were either used immediately or stored at -20°C.   
2.6 RNA Quantification/Purity 
The amount of RNA in a sample was quantified using the NanoVue™ Plus 
Spectrophotometer.  The ultraviolet (UV) absorbance was measured at 260 nm (A260) and the 
concentration of RNA was calculated using the following formula: 
Concentration =  A260 * 40 
The number 40 was the instruments default factor for RNA samples, due to a 40 
g/ml RNA solution of a typical synthetic Oligonucleotide having an optical density of 1.0 A 
in a 10 mm pathlength cell. 
The  NanoVue™ Spectrophotometer also gave an estimation of the purity of the RNA 
sample using the following absorbance ratio (A260/A280).  Proteins, which absorb light in the 
UV spectrum, accompany nucleic acids extracted from cells; extensive purification is 
required to remove any protein impurity.  A pure RNA sample gives an absorbance ratio of ≥ 
2.0. 
 
2.7 Reverse Transcription of RNA  
All RNA extracts were converted to complimentary DNA (cDNA) by reverse 
transcription for use in quantitative real-time PCR.  A recombinant DNA polymerase; 
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Moloney Murine Leukemia Virus (M-MLV) reverse transriptase enzyme (Ambion® Life 
Technologies Ltd, Paisley, UK) was used to synthesise a complementary DNA strand from 
the primer hybridised single-stranded RNA template.  4 l of RNA extract, 4 l of random 
hexamers (Ambion® Life Technologies Ltd, Paisley, UK) and 4 l of nuclease-free water 
(Sigma-Aldrich Company Ltd, Dorset, UK) were added to a 0.2 ml microfuge tube and 
vortexed, the tube was then briefly centrifuged and incubated on a 2720 Thermal Cycler 
(Applied Biosystems® Life Technologies, Paisley, UK) for 3 minutes at 75°C. Due to the 
inability to accurately quantify the RNA extract using the nanovue instrument described 
previously, it was decided that 4l of RNA would be input every time so that at lease a 
consistent amount was added to every reaction.  The extraction techniques and sample 
collection were kept as accurate as possible with every run to help minimise any RNA 
concentration variances in the cDNA.   
After incubation, the tube was removed to ice immediately, then centrifuged briefly 
again and then replaced back on the ice.  Keeping the tube on ice, 1 l of RNase Inhibitor 
(Cloned) 40 U/l, 1 l of M-MLV Reverse Transcriptase (Ambion® Life Technologies, 
Paisley, UK), 2 l of 10X First Strand Synthesis Buffer (supplied with the M-MLV reverse 
transcriptase) and 4 l of 2.5 mM dNTP mix (Promega UK, Southampton, UK), in that order, 
were added to the tube.  Note the 10 mM dNTP was diluted using nuclease-free water (Sigma 
Aldrich Company Ltd, Dorset, UK).  The tube was then gently vortexed and centrifuged 
briefly.  After centrifugation, the tube was then incubated at 43°C for 1 hour, followed by 
92°C for 10 minutes (to inactivate the M-MLV Reverse Transcriptase) on the 2720 Thermal 
Cycler.  Reverse transcription negative controls followed the same protocol, except that the 
M-MLV reverse transcriptase was replaced with 1 l of nuclease-free water.  These negative 
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controls were used in quantitative real-time PCR to test for any DNA contamination.  All 
samples were stored at -20°C until required.    
 
2.8 Relative quantification real-time PCR  
2.8.1 SYBR® Green Chemistry 
Relative quantification (comparative ΔΔCt method) real-time PCR was performed to 
investigate the expression of specific mRNA markers in blood and saliva samples.  Real-time 
PCR was performed on an Applied Biosystem® 7500 Fast Real-Time PCR System using the 
unlabelled gene-specific primers listed in Table 4 and Fast SYBR® Green Master Mix 
(Applied Biosystems® Life Technologies, Paisley, UK).  The unlabelled gene-specific 
sequences were adopted from (Ballantyne and Juusola, 2007a, Juusola and Ballantyne, 2003, 
Haas et al., 2009a, Zubakov et al., 2008) Haas et al (ref) and Zubakov et al (Table 4)   
 
Real-time PCR reactions were carried out at a final volume of 20 l with the 
following reaction mix: 2 l of cDNA sample/BPC grade water (negative controls), 1 l of 
forward and reverse primers, 10 l of Fast SYBR® Green Master Mix and 6 l of BPC grade 
water.  The run method comprised of an activation step at 95°C for 10 min followed by 45 
cycles of amplification at 95°C for 30 s, 60°C for 45 s and 72°C for 30 s.  This was followed 
immediately by a melt curve stage, where the temperature was increased to 95°C for 15 s, 
followed by 60°C for 1 min, the temperature was then increased again at a rate of 1% to 95°C 
for 15 s, followed by 60°C for 15 s.   
SYBR Green is an intercalating dye that fluoresces in its own right, in solution the 
unbound dye exhibits very little fluorescence.  However, in the presence of double stranded 
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DNA (dsDNA), the dye intercalates with the DNA double helix (binds to the minor groove), 
altering the structure of the dye and thus significantly increasing its fluorescence. (Dragan et 
al, 2012)  Therefore, in a PCR reaction, an increase in amplified DNA results in an increase 
of fluorescence.  Unlike hydrolysis probes, intercalating dyes are non-specific i.e. they will 
bind to and report on any dsDNA that is formed during the PCR reaction regardless of what it 
is.  Therefore, additional analysis, involving melting curve analysis and analysis of 
amplification plots is essential with this type of detection chemistry, to ensure correct 
interpretation of results.  
 
Table 4: Unlabelled gene-specific PCR primers used in real-time PCR; (F) forward primer, (R) reverse primer, reference 
gene.  All PCR primers span at least one exon junction to prevent gDNA contamination. 
 
Body 
Fluid 
Gene Primer Sequence Size 
(bp) 
Blood NCF2 F - attacctaggcaaggcgacg R - tctgggtggaggctcagct 100 
 SPTB F – aggatggcttggcctttaat  R – actgccagcaccttcatctt  247 
 PBDG F - tggatccctgaggagggcagaag R - cttgtcccctgtggtggacatagcaat 177 
Saliva KRT4 F - aggaggtcaccatcaaccag R - gctcaaggtttttgctggag 208 
 HTN3 F – gcaaagagacatcatgggta R - gccagtcaaacctccataatc 134 
 KRT13 F – cagagcgtggaggctgacat R - cctccttgttcagctctgcac 295 
 STATH F – cttctgtagtctcatcttg R - tggttgtgggtatagtggttgttc 198 
 SPRR1A F – tggccactggatactgaaca R – cccaaatccatcctcaaatg 213 
Reference 
gene 
18s 
rRNA 
F – ctcaacacgggaaacctcac R - cgctccaccaactaagaacg 110 
 
 
2.8.2 Melting Curve Analysis 
Melting curve analysis is a post-amplification method used to determine the 
specificity of SYBR Green-based real-time PCR assays.  The non-specific nature of the 
SYBR Green dye necessitates a melting curve stage, as a way of identifying and 
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distinguishing the PCR products in the reaction, i.e. confirming whether the products are 
specific amplicons, primer-dimers or other non-specific PCR products.  The analysis is 
performed automatically as per a predefined program, immediately upon completion of 
amplification.  A melt curve is generated by gradually heating the PCR products at a constant 
rate (1%) through a range of temperatures, ~ 60°C to 95°C.   The fluorescence data is 
monitored and collected throughout the process.  At the beginning of the melt curve stage the 
fluorescent signal is high as the DNA is double stranded and the SYBR Green dye is in its 
bound state.  As the temperature increases and the dsDNA is denatured (melted) into ssDNA, 
the SYBR Green dye is released into solution, resulting in a decrease in fluorescence.  
Initially the fluorescence decreases slowly, however, when the melting temperature (Tm) of 
the PCR product is reached, a sudden decrease in fluorescent signal is observed.  The Tm is 
defined as 50% dissociation; where 50% of the product is dsDNA and 50% of the product is 
ssDNA (melted), and is dependent on the product length, the GC content (a higher Tm is 
observed in GC rich PCR products) and sequence content.  The real-time PCR software 
presents the melt curve data as a negative first derivative of fluorescence with respect to 
temperature (-dF/dT vs. T), this is the rate-of-change-of fluorescence rather than absolute 
fluorescence (raw data).  Plotting the data in this way gives a clearer indication of the Tm as 
the melting curve is converted into a melting peak (Figure 2). 
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2.8.3 TaqMan® Chemistry 
Following the SYBR Green based studies, relative quantification real-time PCR 
studies were performed to investigate the expression of specific mRNA markers in blood and 
saliva samples, this time utilising TaqMan chemistry.  Real-time PCR was performed on an 
Applied Biosystem® 7500 Fast Real-Time PCR System using 2x TaqMan® Fast Universal 
PCR Master Mix- no AmpErase® UNG, Eukaryotic 18s rRNA Endogenous Control 
(FAM™/MGB probe, non-primer limited), and 20x TaqMan® Gene Expression Assays 
(Applied Biosystems® Life Technologies, Paisley, UK), listed in Table 5. 
Real-time PCR reactions were carried out at a final volume of 20 l with the 
following reaction mix: 2 l of cDNA sample/BPC grade water (negative controls), 1 l of 
TaqMan® Gene Expression Assay/Eukaryotic 18s rRNA Endogenous Control, 10 l of 
              
Figure 1: (A) Raw melt curve data, where the absolute fluorescence is plotted against the temperature.  High florescence 
is observed at low temperatures as the DNA is double-stranded and the fluorophore is associated with the amplicon.  As 
the temperature increases and the DNA dissociates into ssDNA, the fluorescent signal drops as the dye is released into 
solution. The vertical line represents the temperature at which 50% of the DNA has dissociated. (B) A negative first 
derivative melt curve plot, where the rate-of-change-of fluorescence (-dF/-dT) is plotted against temperature, this plot 
gives a clearer indication of the Tm of the PCR product; the inflection point on the melting curve is converted into a 
melting peak.  
 
B A 
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TaqMan® Fast Universal PCR Master Mix and 7 l of BPC grade water.  All assay probes 
were pre-designed and  span an exon junction.  The run method comprised of an activation 
step at 95°C for 20 s followed by 40 cycles of amplification at 95°C for 3 s and 60°C for 30 s.     
 
Table 5: All TaqMan® gene expression assays consisted of a pair of unlabelled PCR primers and a TaqMan® probe with a 
FAM™ dye label on the 5’ end, and minor groove binder (MGB) and nonfluorescenct quencher (NFQ) on the 3’ end.  The 
eukaryotic 18s rRNA endogenous control assay was also labelled FAM™/MGB. 
 
Body Fluid Gene Gene Name Amplicon Length (bp) 
Blood NCF2 Neutrophil Cytosolic 
Factor 2 
106 
 SPTB Beta-spectrin 129 
Saliva KRT4 Keratin 4 61 
 HTN3 Histatin 3 136 
 KRT13 Keratin 13 75 
 STATH Statherin 90 
Endogenous   
control 
18s rRNA Eukaryotic 18s ribosomal 
RNA 
187 
 
TaqMan® Gene Expression assays utilise hydrolysis probe-based detection chemistry.  
Just as in any PCR, TaqMan assays use an upstream and downstream primer with the addition 
of an internal probe that binds between the two primer-binding sites.  The probes are 
fluorescently labelled sequence-specific oligonucleotides; covalently bonded to the 5’ end of 
the probe is a fluorescent reporter signal (FAM™), and to the 3’ end of the probe is a 
nonfluorescent quencher molecule.  Probes differ to primers in that they are dual-labelled and 
lack a free hydroxyl group on the 3’ end, thus preventing them from being extended by Taq 
polymerase.   When a probe is intact, the reporter dye and quencher molecule are in close 
proximity, and as such the quencher greatly reduces the fluorescence emitted by the reporter 
molecule by Fluorescence Resonance Energy Transfer (FRET).  A TaqMan probe will only 
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anneal between two primer sites if the target sequence is present, they are designed to anneal 
to one strand of the target sequence.  Once annealed, the probe is then cleaved by the 5’ 
exonuclease activity of Taq polymerase during primer extension, releasing the reporter 
molecule into solution and separating the reporter dye from the quencher.  The probe is 
completely displaced as primer extension continues to the end of the template strand, and the 
permanent separation of the quencher and reporter molecule results in an increase reporter 
signal.  Thus, with TaqMan probes, the level of fluorescence detected is directly proportional 
to the amount of amplified target in each PCR cycle.  If no specific target sequence was 
present in the reaction, the fluorescent probe would be unable to hybridise, and as such the 
reporter molecule would remain quenched and no fluorescence would occur.  
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2.8.4 Comparative ΔΔCt Method 
 For all relative quantification studies, the 2- ΔΔCt method (Schmittgen and Livak 2001) 
was used to analyse the fold change of mRNA specific markers in blood and saliva samples.  
The 7500 Fast Real-Time PCR software v2.0.6 was used to calculate the threshold cycle (Ct), 
which is defined as the number of PCR cycles required for the fluorescent signal to exceed 
background level.  All genes of interest were normalised to the house keeping gene 18s 
rRNA, the results were expressed as a fold change (2- ΔΔCt) and were calculated as follows: 
 
Ct
 GOI
s
 – Ct
 norm
s
 = Δ Ct
 sample 
Ct
 GOI
c
 – Ct
 norm
c
 = ΔCt
 calibrator 
Ct
 sample – Ct calibrator = ΔΔ Ct 
Fold change = 2- ΔΔCt
 
 Where, GOI represents gene of interest, norm represents normaliser/endogenous 
control, S represents sample and C represents calibrator.   Results were also expressed as ΔCt 
to compare and illustrate the expression levels (normalised to the endogenous control) of 
specific markers in blood and saliva.  
 
2.8.5 Statistical analysis 
All statistical analyses were performed using IBM® SPSS® Statistics v20 software.  The 
results were expressed as mean ± standard error of the mean (SEM) for (n), where n 
represents the number of replicates.  Statistical differences were calculated using the paired 
samples t-test and expressed as a p-value ≤ 0.05 (*) and/or ≤ 0.01 (**).  Error bars in the gene 
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expression plots were based on the RQ minimum and RQ maximum data calculated by the 
real-time PCR software, the calculations for which are as follows:   
 
 
RQ Minimum  
CI = m - tdf 0.95 (sd/N) 
 
RQ Maximum  
CI = m + tdf 0.95 (sd/N) 
 
 
Where CI represents confidence interval at 95%, m – average Ct, tdf  – t value for degrees of 
freedom, sd – standard deviation, and N – the number of replicates.  Error bars in the ΔCt 
charts were based on mean ± SEM for (n). 
 Each results was presented as a comparison of male and female expression in each 
sample, the rationale behind this was simply that one volunteer was male and the other female 
consistently throughout the study, no previous literature has described any difference in 
gender however, it was thought it may be interesting given that it was a consistent factor 
throughout having both a male and female, to see if there were any distinct differences 
between genders.  
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Chapter 3 
 
Body Fluid Identification Utilising Fast SYBR® Green Master 
Mix and Real-Time PCR 
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Introduction 
A series of qPCR relative quantitation analysis studies were undertaken, investigating 
the expression of mRNA specific markers in blood and saliva samples. Initial studies were 
based on the use of SYBR® Green detection chemistry utilising real-time PCR, these were 
then followed by a series of comparison studies utilising TaqMan® Gene Expression Assays.  
Due to the non-specific nature of the SYBR Green fluorescent dye, melt curve analysis was 
performed to assist in determining whether or not the target sequence had been amplified, and 
to distinguish this from primer-dimer amplification and other non-specific PCR amplification 
when necessary.  Post amplification analysis was not possible or necessary for studies using 
TaqMan assays.  Firstly, in a TaqMan reaction, the fluorophore does not remain associated 
with the amplicon post PCR and secondly, hydrolysis probes are highly specific in that a 
fluorescent signal is only detected when the primers and probe bind to the specific target, 
unlike SYBR Green that will bind to any dsDNA in the PCR reaction.  As described in the 
materials and methods, typically for one study two volunteers provided two samples, a blood 
and saliva sample, these were then replicated three times on the plate and the number of 
specific markers varied per study.  
Male blood was used as the calibrator in each result, this remained as such for 
consistency throughout the results and statistical analysis  However, this has no bearing on 
the result i.e. the calibrator sample could have been set to saliva for each study, the outcome 
would be the same only the graph would be reverse i.e. any saliva samples that were down 
regulated would now be up-regulated and vice versa, the same applies to the blood samples 
too; any down regulation observed in blood samples while blood was a calibrator, would 
change to up-regualtion and vice versa if a saliva calibrator was chose, the results are all 
relative. 
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 Reference gene 18s rRNA was used in all studies, the expression levels of this 
gene in both blood and saliva were investigated and compared using the Ct values.  
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3.1 A quantitative comparison of blood and saliva specific markers in blood and 
saliva stains utilising SYBR® Green dye, and 18s rRNA endogenous control. 
3.1.1 Relative quantitation (RQ) and ΔCt expression of specific markers PBGD, NCF2, 
SPTB, HTN3, STATH and KRT4 
 
 
Figure 2: Relative expression of blood-targeted genes NCF2 and SPTB, and saliva-targeted gene KRT4 in blood and saliva 
stains. The results were normalised to reference gene 18s rRNA and expressed as a fold difference, the calibrator sample in 
each experiment was blood.  Error bars based on RQ minimum and maximum data, n =  3.  NCF2 p ≤ 0.01, KRT4 p ≤ 0.05 
and SPTB p ≤ 0.01.   
 
Figure 2 corresponds to three separate studies, the results shown are for the mRNA 
markers that exhibited detectable amplification in both blood and saliva samples.  A list of the 
specific markers investigated in each study can be seen in Table 6.  Blood specific marker 
PBGD and saliva specific marker HTN3 showed no detectable amplification in any study.  
KRT4 was detected in one out of two studies and STATH, a saliva specific marker, was 
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detected in two studies but only in one sample.  As such, a comparative analysis was not 
possible for this marker in these particular studies; however the ΔCt values can be seen in 
Figure 4.  Blood specific marker NCF2 was detected in both blood and saliva samples in two 
separate studies; the number (1) was therefore allocated to this marker in Figure 2 to show 
that this result was from a separate study.      
 
Table 6: A list of the blood and saliva-specific markers investigated in each study.  The specific-markers highlighted in red 
showed no detectable amplification, * indicates markers that showed detectable amplification in one body fluid. 
 
Study Blood-specific marker Saliva-specific marker 
1 NCF2 KRT4 
2 
SPTB 
PBGD 
STATH* 
HTN3 
3 
NCF2 
PBGD 
STATH* 
HTN3 
KRT4 
 
The results in figure 2 revealed an up-regulation for KRT4 in saliva (2.53), indicating 
an over expression of KRT4 in saliva compared to blood.  In contrast, a down-regulation for 
NCF2 and NCF2 (1), was observed in saliva (-1.36 and – 0.72), and also SPTB (-4.09), 
indicating an under expression of both these markers in saliva compared to blood (Figure 2). 
Statistical analysis demonstrated that the expression of NCF2 and SPTB was 
significantly lower in saliva than in blood (p ≤ 0.01; Table 7), and that the expression of 
KRT4 was significantly higher in saliva than in blood (p ≤ 0.02; Table 7).   
A significant difference however, could not be obtained for NCF2 (1) in blood and 
saliva.  This was due to the NCF2 marker in this particular study showing amplification in all 
replicates for blood but only one replicate for saliva, as NCF2 was not detected in two 
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replicates.  Despite being able to do a statistical comparison, this didn’t negate the results as 
NCF2 was detected in all blood replicates yet only one saliva replicate, thus supporting the 
specificity of this blood marker.  Error bars are only seen on NCF2 (1) in blood and not saliva 
due to the lack of amplification in saliva.   
Analysis of the ΔCt values for this data (the threshold cycle value post normalisation 
to the endogenous control) demonstrated there was a higher expression of NCF2 (1) in blood 
compared to saliva (Figure 3, Table 7), thus further supporting the specificity of NCF2 in 
blood.  A low ΔCt value corresponds to a high expression level of specific mRNA. 
As expected, the results in Figure 2 revealed high specificity for blood specific 
markers NCF2 and SPTB, and saliva specific marker KRT4.  Each marker showed 
amplification in both body fluids however, the expression of blood-specific markers NCF2 
and SPTB were significantly higher in blood than saliva, and the expression of saliva-specific 
marker KRT4 was significantly higher in saliva than in blood.  For NCF2 (1), even though no 
significant difference was observed in that particular study, a higher expression was observed 
in blood compared to saliva based on the ΔCt values (Figure 3). 
Unexpectedly, markers PBGD and HTN3 showed no amplification in either body 
fluid in any study.  It was expected that each specific marker would show some level of 
expression in either the blood and/or saliva samples.  However, this was not the case, and 
although KRT4 was detected in one study (Figure 2), a repeat study showed zero detectable 
amplification for this marker (Table 6).  
STATH on the other hand was detected in both studies, in each study however, this 
marker was only present in one body fluid rather than both (Table 6).  In one study, this 
marker was detected in blood and not saliva, and vice-versa in another study, the results can 
be seen in Figure 3.  STATH detected in the blood sample had a ΔCt value of 13.67, this 
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result however was based on amplification occurring in one out of three replicates, (a positive 
result in that two replicates out of three showed zero amplification for this saliva specific 
marker in blood), thus giving an inaccurate ΔCt value.  The raw Ct value (Ct being the 
threshold cycle value prior to normalisation) for this replicate was very high (42.07), an 
indication of very-low level expression, as the higher the Ct value the lower the expression.  
The melt curve data for this sample demonstrated typical primer-dimer characteristics, thus 
suggesting that the amplification in this sample was non-specific.  STATH detected in the 
saliva sample in a separate study- denoted (1), had a Ct value of 16.22 ± 0.49 (Figure 3, Table 
7).   This result initially indicated that STATH was expressed in all three replicates and 
showed specificity to saliva given that no expression had occurred in the blood sample.  
However, analysis of the melt curve demonstrated that the fluorescence detected in this 
sample was more than likely due to primer-dimer artefacts, exhibiting a small peak with a low 
melting temperature (Tm) value ~69°C.  It can therefore be said that STATH was not 
expressed in either blood or saliva in any of these studies. 
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Figure 3: qRT-PCR ΔCt values for blood and saliva-specific markers in blood and saliva stains. Results are mean ± SEM, n 
=  3 (except for STATH in blood and NCF2 (1) in saliva, where n =  1). Low ΔCt values correspond to a high expression level 
of the specific mRNA.   
 
Table 7: ΔCt values for blood and saliva targeted genes in blood and saliva stains.  Results are mean ± SEM, n =  3 (except 
for STATH in blood and NCF2 (1) in saliva, where n =  1).  Zero values correspond to no expression of target, p ≤ 0.05 for 
NCF2, KRT4 and SPTB. 
 
Marker ΔCt value  p - value 
 Blood Saliva (≤ 0.05) 
NCF2 16.07 ± 0.25 20.60 ± 0.14 0.01 
KRT4 21.08 ± 1.26 12.66 ± 0.17 0.02 
SPTB 3.70 ± 1.40 17.30 ± 0.41 0.01 
STATH 13.67 0.00 - 
NCF2 (1) 13.70 ± 0.25 16.10 - 
STATH (1) 0.00 16.22 ± 0.49 - 
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3.1.2 Expression of endogenous control 18s rRNA in blood and saliva stains. 
 In theory, an ideal endogenous control should be expressed at a constant level in 
different tissues.  However, this was not the case in these three studies, where the expression 
levels of 18s rRNA was different in blood and saliva.  Statistical analysis demonstrated that in 
each study 18s rRNA was significantly higher in saliva than in blood (p ≤ 0.05; Table 8).   
A possible explanation for this difference could be due to yield during the sample 
collection process, i.e. the amount of epithelial cells collected with a buccal swab compared 
to the number of cells collected from the finger prick method for the blood stains.  Since 18s 
rRNA is a reference gene, a higher number of cells in the saliva sample would give a higher 
expression of the gene in that sample compared to blood.   
 
Table 8: Raw Ct values for endogenous control 18s rRNA in blood and saliva stains.  Results are mean ± SEM, n =  3.  A low 
Ct value corresponds to a higher expression of the endogenous control, p ≤ 0.05 in all studies.   
 
Study 18s rRNA Ct value  p - value 
 Blood Saliva (≤ 0.05) 
1 18.05 ± 0.05 11.09 ± 0.07 0.00 
2 28.40 ± 1.33 13.17 ± 0.27 0.01 
3 27.06 ± 0.04 24.90 ± 0.35 0.02 
 
 
3.1.3 Negative Control Amplification and Melt Curve Analysis 
SYBR® Green is an intercalating dye which has non-specific binding properties, i.e. it 
is able to detect non-specific double-stranded reaction products.  Melt curve analysis and 
analysis of the negative controls was therefore an additional test that could be used to validate 
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that the detected amplification was the result of a targeted amplicon rather than non-specific 
amplification or contamination.   
The expression of STATH in the saliva sample in study 3 (Table 6) was a good 
example of this.  Prior to melt curve analysis, the ΔCt values indicated good marker 
specificity – the saliva specific marker was detected in the saliva sample (amplification was 
observed in all three replicates) and not blood.  However, analysis of the melting peaks for 
this amplification demonstrated that each replicate exhibited a low Tm, this along with the size 
of the peaks and their intensity, was characteristic for primer-dimer artefacts. Without the 
melt curve data, this result based on ΔCt values alone, may have been misinterpreted for 
specific amplification.   
Amplification was detected in all 18s negative control samples (NTC) in each study.  
Analysis of the melt curve data demonstrated that the melting peak for 18s NTC in each study 
consistently peaked at the same Tm as the blood and saliva samples ~81 °C, an indication that 
the fluorescence detected in each sample (including the NTC) corresponded to specific 
amplification. The intensity of the NTC peaks however was much smaller than the blood and 
saliva samples (Figure 4; Table 9).   
 
Table 9: Ct and Tm values for 18s rRNA negative control samples (NTC), and Tm values for 18s rRNA in blood and saliva 
samples in each study.  Results are mean ± SEM, n =  3. 
 
Study 18s rRNA  18s rRNA Tm  value  (°C) 
 NTC Ct value Tm  value  (°C) Blood Saliva 
1 30.71 ± 0.04 81.08 ± 0.06 81.40 ± 0.06 81.14 ± 0.11 
2 39.82 ± 0.55 80.46 ± 0.00 80.40 ± 0.16 80.40 ± 0.12 
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3 43.76 ± 0.42 81.03 ± 0.06 81.16 ± 0.11 81.16 ± 0.00 
 
Figure 4, illustrates a typical melt curve of this data, note that in each study the same 
melt curve was obtained for 18s.   
 
Figure 4: Melt curve analysis of endogenous control 18s rRNA in the negative control, blood and saliva samples.  The 
fluorescence detected in all four samples corresponds to the target amplicon, indicating the expression of 18s rRNA in all 
samples, a lower intensity is observed for the NTC peaks. 
 
 
Saliva 
Blood 
NTC 
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Based on the Ct values, the expression that occurred in the 18s NTC samples was 
much lower compared to the blood and saliva samples in each study (Table 8 and 9).  It was 
expected that some level of amplification would be observed in the NTCs for 18s rRNA, 
given its ubiquitous nature; ribosomal RNAs are highly abundant contributing up to >80% of 
total cellular RNA, this coupled with the lack of specificity of SYBR® Green could be a 
possible explanation for this detectable amplification.  
It can be seen from Table 10 that NTC amplification was also observed in the KRT4 
NTC sample in study 1, and the SPTB NTC sample in study 2.  No amplification was 
detected in any other NTC sample.     
 
Table 10: Negative control Ct values for specific-markers in each study, the result =  mean, n =  3.  
 
Study Specific-marker Ct value for NTC 
1 
NCF2 
KRT4 
- 
39.28 
2 
SPTB 
PBGD 
STATH 
HTN3 
35.22 
- 
- 
- 
3 
NCF2 
PBGD 
STATH 
HTN3 
KRT4 
- 
- 
- 
- 
- 
 
Analysis of the raw Ct values for KRT4 in study 1 demonstrated that the amplification 
observed in the KRT4 NTC sample was very similar to that of KRT4 in blood (Ct values; 
39.28 and 39.57 respectively).  Both of which are high Ct values; the maximum number of 
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cycles in this study was 45 (Ct max), therefore indicating a low level of expression in both of 
these samples.  For comparison purposes, the Ct value for KRT4 in saliva was much lower 
(23.75), this lower value supporting the specificity of this marker for saliva. 
Analysis of the melt curves for these three samples demonstrated that the Tm values 
for the KRT4 NTC sample and KRT4 blood sample were also very similar to one another 
(73.21°C and 72.96°C respectively), and that the Tm value for the KRT4 saliva sample 
however, was significantly higher (82.54°C, p ≤0.01; Figure 5, Table 11).   
 
Table 11: Melting temperature (Tm) values for saliva-specific marker KRT4 in the negative control, blood and saliva 
samples.  Results are mean ± SEM, n = 3, p ≤ 0.01** 
 
Sample Tm (°C) 
KRT4 NTC 73.21 ± 0.23 
KRT4 Blood 72.96 ± 0.44 
KRT4 Saliva        82.54 ± 0.06 (**) 
 
Such melting characteristics suggest that the fluorescence detected in the KRT4 saliva 
sample corresponds to the targeted amplicon.  The KRT4 saliva peak shows a much higher 
intensity in comparison to the melting peaks observed for the KRT4 NTC sample and KRT4 
blood sample, and also exhibits a higher Tm value (Figure 5).    This melt curve data coupled 
with the RQ data, supports the specificity of this marker in this particular study.   
The melting peaks observed for the KRT4 NTC and KRT4 blood samples are much 
smaller in comparison to the saliva peak and exhibit lower melting temperatures, which 
suggests they are non-specific amplification products.   The fluorescence detected in these 
samples is more than likely the result of primer-dimer artefacts, which in a melt curve are 
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usually observed by the presence of a smaller hump or shoulder to the left of the main peak 
(Figure 5).  Primer-dimer artefacts are usually comprised of short nucleic acid sequences – 
shorter than targeted amplicons, and therefore denature at a lower temperature.  The 
formation of primer-dimers in the NTC samples, and what looks like possibly the blood 
sample in this case too, most often occurs where there is an abundance of primer and no 
template.  It is also possible again given the nature of SYBR® Green and its lack in specificity 
that this amplification is due to low level contamination, or a result of background 
fluorescence from the SYBR® Green chemistry.   
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Figure 5: Melt curve analysis for saliva-specific marker KRT4 in the negative control, blood and saliva  samples.   
 
The amplification observed in the SPTB NTC sample in study 2 (Table 10), gave a Ct 
value of 35.22.  This was slightly higher than the Ct values observed in the SPTB blood and 
saliva samples (32.10 and 30.40 respectively).   
The melt curve data for these three samples demonstrated that each sample (including 
the NTC sample) exhibited two peaks.  The main melting peaks in each sample peaked at the 
Saliva 
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same Tm ~72 °C, an indication that the fluorescence detected in each sample may have been 
due to specific amplification.  The second peak for each sample also peaked at the same Tm 
~66 °C (Figure 6), a possible indication of primer-dimer artefacts.  Unlike KRT4 in Figure 6, 
where the NTC amplification was shown to be non-specific, the SPTB NTC sample gave the 
same Tm as the blood and saliva melting peaks.  This data could be an indication that low 
level contamination may have occurred in the sample, or it could be that non-specific 
amplification is being observed in all three samples, melt curve data is not definitive it only 
supports the RQ data and offers increased specificity for the SYBR® Green dye (Figure 6).   
Even though no amplification was detected in the NCF2 NTC sample in either study 
(Table 10), analysis of the melt curves was still undertaken.  The results demonstrated that the 
melt curves for NCF2 in blood and saliva were the same in both studies, and that in each case 
the data suggests that the amplification observed in the NCF2 samples was more than likely 
due to the targeted amplicon.  These discrepancies in the NTC amplification (Table 8) i.e. 
zero amplification in some NTCs, yet amplification in others, could possibly be a result of the 
sensitivity of the real-time PCR reaction. 
Figure 7 illustrates the typical melt curve for NCF2 marker in blood and saliva 
samples.  Both samples exhibit two large peaks, showing high intensity with a Tm value of 
~82°C and smaller peak/hump to the left with a lower intensity and Tm value of ~68°C.  
These melting characteristics suggest that the larger peaks correspond to the targeted 
amplicon NCF2, and that the smaller peaks more than likely correspond to primer-dimer 
artefacts. This result supports the RQ data by suggesting that NCF2 is present in both blood 
and saliva, and also supports the specificity of NCF2 given that a higher expression of this 
blood specific marker was observed in blood (Figure 7).  
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Figure 6: Melt curve analysis for blood-specific marker SPTB in the negative control, blood and saliva samples. 
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Figure 7: Melt curve analysis for blood-specific marker NCF2 in the following samples: negative control, blood and saliva.   
 
3.1.4 Reverse transcription negative control amplification 
 Amplification was detected in 3 out of 18 reverse transcription negative control (RT 
NTC) samples across all three studies.  In the first study, amplification was detected in the 
18s blood RT NTC and NCF2 blood RT NTC.  In the third study, amplification was detected 
in the STATH saliva RT NTC. 
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Analysis of the 18s blood RT NTC in study one revealed that the amplified product 
gave a similar Ct value (29.48) to the 18s NTC sample (Table 9), both of which were higher 
than the Ct values for 18s in blood and saliva (Table 8), indicating a lower level of 
expression.  The melt curve data for this sample also demonstrated that the melting peak of 
the 18s blood RT NTC peaked at the same Tm as the 18s NTC, blood and saliva samples 
(Figure 4), indicating that the fluorescence detected in that sample was due to specific 
amplification of 18s rRNA.  However, the peak had a much smaller intensity compared with 
all other peaks. This result may therefore be due to low level contamination or a result of 
background fluorescence. 
 Analysis of the NCF2 blood RT NTC in study one revealed that the amplified product 
gave a raw Ct value of 41.49.  This value is much higher than the Ct values observed for 
NCF2 in the blood and saliva samples (34.57 and 31.69 respectively), and very close to the Ct 
max value of 45, indicating that the levels of expression observed in the RT NTC sample are 
very low.  The melt curve data for this RT NTC sample suggested non-specific amplification, 
as the peak was smaller and exhibited a lower Tm value than the sample peaks (Figure 8).  
The amplified product in the NCF2 RT NTC sample is either due to primer-dimers artefacts 
or a result low level fluorescence, most likely due to the lack of specificity of the SYBR® 
Green.  It is unlikely to be the result of a poor RNA extraction method as amplification would 
be seen in all RT NTCs and this was not the case. 
It is worth noting that the number of PCR cycles (Ct max) was set to 45 in this 
particular study, had the cycle number been set to 40 (a standard PCR cycle number) no 
amplification would have been detected in the NCF2 blood RT NTC sample, thus indicating 
that there may be an issue with the test being too-sensitive.   
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Figure 8: Melt curve analysis for NCF2 in the reverse transcription NTC samples compared to blood.   
 
Analysis of the STATH saliva RT NTC in study three revealed that the amplified 
product gave a Ct value of 42.90, very similar to the STATH saliva sample which was 
revealed early on in this chapter to be primer-dimer amplification.  The melt curve data for 
this RT NTC was also the same as the STATH saliva sample, the peak having a Tm value of 
~69°C.  Thus all the data suggests primer-dimer formation in this particular sample. 
No other sample in study three showed amplification in the RT blank NTCs, the 
NCF2 (1) RT NTC sample was also negative.  Thus, strongly supporting the probability that 
Blood 
RT 
NTC  
67 
 
the amplification observed in the NCF2 blood and saliva samples was a result of amplifying 
the targeted amplicon and not due to contaminating DNA or non-specific amplification.  This 
RT NTC data along with the melt curve and RQ data again supports the specificity of this 
blood-specific marker. 
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3.2 A quantitative comparison of blood and saliva specific markers in male and 
female blood and saliva stains, utilising SYBR® Green dye and 18s rRNA 
endogenous control 
3.2.1 Relative quantitation and ΔCt expression of specific markers STATH and SPTB 
Figure 9: Relative expression of blood-targeted gene SPTB and saliva-targeted gene STATH in male and female blood and 
saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold difference, the calibrator 
sample in each experiment was male blood.  Error bars were calculated using the RQ minimum and maximum data, n =  3.  
 
In this part of the study, a number of quantitative analysis studies were performed to 
investigate the expression and specificity of blood and saliva specific mRNA markers in male 
and female blood and saliva stains.   
The results in Figure 9 were based on two separate studies investigating the 
expression of saliva-specific marker STATH and blood-specific marker SPTB in both male 
and female blood and saliva stains (the second study denoted by the number 1 in Figures 9 
and 10).   
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The results of the first study revealed a down regulation of STATH in all three 
samples compared to male blood.  Thus, indicating that the saliva specific marker was over 
expressed in male blood.  A down-regulation of SPTB was also observed in all three samples 
compared to male blood.  Thus, indicating that the blood specific marker was over expressed 
in male blood.  The results from the second study revealed the same results as the first; a 
down regulation of both markers in all three samples compared to the male blood sample. 
For these both these markers it was expected that STATH would be over expressed in 
saliva given that it is saliva specific, and that SPTB would be over expressed in blood given 
that it is blood specific.  The latter occurred in both studies, (a higher expression of SPTB in 
blood than saliva) thus suggesting a positive result for the specificity of SPTB.  STATH 
however, based on these results, appeared to lack specificity for saliva; the results 
demonstrated there was more STATH present in the male blood sample than any other 
sample.   
Statistical analysis demonstrated that the expression of SPTB and STATH was 
significantly lower in saliva compared to blood in both male and female samples (p ≤0.05; 
Table 12).   
 Interestingly, it was also observed that in both studies the expression of each marker 
was higher in the male samples compared to the female samples (Figure 10).  Although in the 
first study there was no significant difference between the expression levels of SPTB in male 
and female blood samples.   
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Table 12: ΔCt values for blood targeted gene SPTB and saliva targeted gene STATH in male and female blood and saliva 
stains.  The results are mean ± SEM, n =  3, (p ≤0.05*; p ≤0.01**)   
 
Marker ΔCt Value 
 Male Blood Male Saliva Female Blood Female Saliva 
SPTB -0.52 ± 2.08 11.83 ± 0.26** 0.94 ± 1.00 10.97 ± 0.17** 
STATH 2.51 ± 0.66 12.99 ± 0.22** 5.76 ± 0.69 11.62 ± 0.25* 
SPTB (1) 2.42 ± 0.10 11.95 ± 0.11** 8.26 ± 0.44 16.05 ± 0.05** 
STATH (1) 3.40 ± 0.17 12.61 ± 0.22** 8.56 ± 0.42 16.71 ± 0.18** 
 
 
Figure 10: qRT-PCR for blood and saliva-specific markers in male and female blood and saliva stains.  Results are mean ± 
SEM, n =  3.  Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
Another noted observation included the consistent expression pattern of both markers 
in the male saliva samples in both studies, Figure 10 and the data in Table 12 illustrates the 
similarity in the ΔCt values.  It can also be seen looking at the data for the second study, that 
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the expression levels of each marker in the male and female samples were almost identical.   
In both studies the expression of SPTB was also higher in the male sample than in female. 
 
3.2.2 Negative control amplification and melt curve analysis  
 In each study, a negative control sample was investigated for each marker including 
the 18s endogenous control.  Amplification was detected in all these samples in both studies.  
The NTC expression levels for each target in study one were slightly higher than the 
expression levels observed in study 2 and statistical analysis demonstrated this difference to 
be significant. (p ≤0.05).   
An individual analysis of the NTCs in both studies revealed that the Ct value for the 
STATH NTC was significantly higher than the Ct values observed in the corresponding test 
samples i.e. male and female blood and saliva in both studies, indicating a lower level of 
expression.  However, analysis of the melt curve data demonstrated that in each study, all five 
samples peaked at almost the same Tm ~68°C, and that a second peak was absent.  Both 
indicators that the amplification observed in each of these samples were more than likely due 
to primer-dimer artefacts.   
The Ct value for the SPTB NTC sample in the first study was quite similar to the test 
samples, with the exception of male saliva and female blood, which were significantly lower, 
thus indicating a higher level of expression in these two test samples.  The Ct value for SPTB 
NTC in the second study was significantly lower in all test samples apart from the female 
blood sample.  The melt curve data for SPTB was similar to the previous results in this 
chapter with regards to the Tm values.  However the peaks appeared slightly different; no 
smaller peaks were observed in these studies.  These results suggest that the amplification in 
the NTC sample is more than likely due to specific amplification. 
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Lastly, the Ct values for 18s NTC were significantly higher than all the corresponding 
test samples in each study, indicating that the expression in the 18s NTC sample was lower.  
The melt curve data for the 18s NTC samples in these two studies were almost identical, yet 
both melting profiles differed slightly in comparison to previous 18s NTC melting results in 
this chapter.  The difference being that two peaks were observed in the profile for the 18s 
NTC samples as opposed to one.  The main Tm peaks also had a slightly lower Tm value than 
previously reported ~79°C and the second peaks appear to be ~71°C; possibly non-specific 
amplification.  The melting peaks, like previous results, were much lower in intensity 
compared to test sample peaks.  In any case, this melting curve analysis along with the 
negative control amplification (a higher Ct value observed in the NTC compared to test 
samples) suggests that the amplification observed in the 18s NTC samples in both studies was 
most probably due to low level specific amplification, as all the main peaks of the NTC 
samples peaked around the same Tm as the test sample.  Again, low level specific 
amplification was expected due to the ubiquitous nature of reference gene 18s rRNA and the 
non-specific nature of SYBR® Green dye.  
3.2.3 Reverse Transcription negative control amplification 
In the first study, amplification occurred in all RT NTC samples for STATH, except 
in the male blood sample, all RT NTCs in the second study also showed amplification.  
Analysis of the Ct values for this data demonstrated that in both studies the level of 
expression observed in the RT NTCs were similar to the expression observed in their 
corresponding test samples.  For STATH RT NTC samples in both studies the melt curve data 
was almost identical; both demonstrated melting peaks at the same Tm, and in each melt curve 
the peaks for the RT NTCs peaked at the same Tm as the test samples.  Indication that the 
amplification observed in these samples, (just like the STATH NTC and test samples) was 
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Unlike previous SPTB studies, amplification was observed in the SPTB RT NTC 
samples in both these studies. One SPTB RT NTC sample in the first study (male blood - the 
rest demonstrated zero amplification), and all SPTB RT NTCs in the second study.  The Ct 
values for each of these RT NTC samples were also similar to the Ct values of the 
corresponding test samples.  The melt curve data for all amplified SPTB RT NTCs across 
both studies were almost identical; in each case the RT NTC sample exhibited peaks at the 
same Tm as the test and NTC samples, thus casting doubt as to whether or not the 
amplification observed in the SPTB samples was due to specific amplification. 
 No amplification was detected for the 18s RT NTCs in the first study, however in 
contrast, all 18s RT NTCs in the second study showed detectable amplification.  All Ct values 
for these RT NTCs were higher than their corresponding test samples, indicating a much 
lower level of expression.  Melt curve analysis suggested that this amplification was specific 
to 18s, as the peaks in the RT NTCs peaked at the same Tm as the test samples, the intensity 
of the RT NTC peaks however was much smaller.  This specific amplification could be due to 
the sensitivity of the real-time PCR coupled with the nature of the 18s rRNA gene and 
SYBR® Green dye.  
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3.2.4 Relative quantitation and ΔCt expression of specific markers KRT13 and SPTB  
Figure 11: Relative expression of blood-targeted gene SPTB and saliva-targeted gene KRT13 in male and female blood and 
saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold difference.  The calibrator 
sample in each experiment was male blood.  Error bars were calculated using the RQ minimum and maximum data, n =  3.  
 
The results in Figure 11 were based on three separate studies investigating the 
expression of saliva-specific marker KRT13, and again blood-specific marker SPTB in both 
male and female blood and saliva stains (the second and third studies are denoted by the 
numbers 1 and 2).   
The results of the first study in Figure 11 revealed an up-regulation of KRT13 in male 
saliva (0.63) and female blood (0.36), yet a down regulation in female saliva (-0.63).  Thus, 
indicating that the saliva specific marker was under expressed in male blood compared to 
male saliva and female blood, and over expressed in male blood compared to female saliva.  
You would expect, given that the KRT13 marker is saliva-specific, an under expression of 
KRT13 in male blood compared to both male and female saliva, however this was not the 
case. Interestingly in this study, an up-regulation of SPTB was observed in the male saliva 
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sample (0.35), indicating that there was more SPTB present in male saliva compared to male 
blood.  A result you would not expect given the SPTB is blood specific.  In all previous 
studies, SPTB has been consistently under expressed in saliva, this was the first time an over 
expression of SPTB in saliva was observed.  For the female blood and saliva samples, an 
under expression of SPTB was observed compared to the male blood sample (-0.35 and -2.32 
respectively). 
The results from the second study in Figure 11 revealed a down regulation for KRT13 
(KRT13 1) in the male saliva sample this time (-0.33), and an up regulation in female saliva 
(0.35) – the opposite of study one.  Suggesting that there was less KRT13 marker present in 
the male saliva sample compared to male blood, yet more present in the female saliva sample.  
You would ideally expect a higher expression of KRT13 in both male and female saliva 
samples compared to blood.  An up-regulation was also observed for this marker in female 
blood (0.10).  SPTB in this second study (SPTB 1) was under expressed in both male and 
female saliva samples compared to the male blood sample (-1.75 and -1.81 respectively), 
whereas an over expression was observed in the female blood sample (0.21).  Indicating that 
there was more SPTB in male blood than both saliva samples, a result you would expect for a 
blood-specific marker, but less in the male blood sample compared to female blood, 
suggesting that the expression levels of this marker vary between donors and in this particular 
study were higher in the female sample. 
The results from the third study in Figure 11 revealed KRT13 (KRT13 2) to be under 
expressed in male saliva, female blood and female saliva (-3.10, -0.88 and – 1.89 
respectively), meaning a higher expression of KRT13 was observed in male blood.  An 
unexpected result, as KRT13 is saliva-specific, therefore you would expect a higher 
expression in saliva samples compared to blood.  The SPTB marker (SPTB 2) was again 
under expressed in both the male and female saliva samples compared to blood (-2.69 and -
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1.35 respectively) , a positive result with regards to specificity for this blood marker as you 
would a higher expression of SPTB in blood.  An over expression of SPTB was again 
observed in the female blood sample (0.35) just as in study 2 (SPTB 1), indicating a higher 
level of the SPTB blood marker in female blood in this particular study.  
For these markers it was expected that KRT13 would be over expressed in saliva 
given that it is saliva specific, and that SPTB would be over expressed in blood given that it is 
blood specific.  The expression of KRT13 varied among samples; in some cases it would be 
higher in saliva than blood and vice-versa , showing little specificity for saliva.  For SPTB an 
over expression was observed once in male saliva, yet the remaining samples showed good 
specificity for blood, in fact two female blood samples showed a higher expression of SPTB 
than in the male blood sample.  
  In the first study, statistical analyses demonstrated that there was a significant 
difference in the higher expression of KRT13 in male saliva compared to male blood, there 
was also a significant difference in the higher expression levels of this marker in female blood 
compared to female saliva, no significant difference in the higher expression of SPTB in male 
saliva compared to male blood.  SPTB however, was significantly lower in female saliva 
compared to female blood (p ≤0.05; Table 13).   
In the second study, there was no significant difference in the expression of KRT13 
(1) in either male or female blood and saliva samples. SPTB (1) however, was significantly 
lower in male saliva compared to male blood and in female saliva compared to female blood 
(p ≤0.01).    
In the third study, the expression of KRT13 (2) was significantly lower in male saliva 
compared to male blood (p ≤0.01).  This marker was also significantly lower in female saliva 
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compared to female blood (p ≤0.05).  SPTB (2) was again significantly lower in male saliva 
compared to male blood, and in female saliva compared to female blood (p ≤0.01).    
Table 13: ΔCt values for blood targeted gene SPTB and saliva targeted gene KRT13 in male and female blood and saliva 
stains.  The results are mean ± SEM, n = 3, (p ≤0.05*; p ≤0.01**). 
 
Marker ΔCt Value 
 Male Blood Male Saliva Female Blood Female Saliva 
KRT13 15.26 ± 0.22 13.17 ± 0.16** 14.06 ± 0.41 17.36 ± 0.49** 
SPTB 11.91 ± 0.24 10.73 ± 0.16 13.09 ± 10.2 19.63 ± 0.65* 
KRT13 (1) 12.18 ± 0.52 13.28 ± 1.71 11.03 ± 0.27 11.83 ± 0.40 
SPTB (1) 6.81 ± 0.48 12.62 ± 0.98** 6.12 ± 0.22 12.83 ± 0.16** 
KRT13 (2) 5.79 ± 0.38 16.07 ± 0.19** 8.70 ± 0.86 12.08  ± 0.25* 
SPTB (2) 3.54 ± 0.14 12.48 ± 0.10** 2.38 ± 0.09 8.04 ± 0.19** 
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Figure 12: qRT-PCR for blood and saliva-specific markers in male and female blood and saliva stains.  Results are mean ± 
SEM, n =  3.  Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
Observation of the ΔCt values again demonstrates an almost consistent expression 
pattern for male saliva in each study for both markers (Figure 12), interestingly, there does 
however in each study, appear to be more SPTB present in male saliva than KRT13.  The 
expression patterns for the other three samples however vary between studies. 
In figure 12, comparison of the ΔCt values for male and female samples in the first 
study shows that there was a higher expression of KRT13 in male saliva than female saliva, 
and that this was vice-versa  in the second and third study, an indication that KRT13 
expression levels vary between individuals, which is something you would expect.  However, 
according to the ΔCt results, even though expression was observed in the saliva samples for 
KRT13 which is saliva-specific, each study unexpectedly demonstrated a higher expression 
of KRT13 in all blood samples compared to saliva. 
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In each study, the expression levels of SPTB in both male and female samples were 
relatively close, variation in expression can be seen between donors i.e. a higher expression 
can be seen the male blood sample in study one, yet the expression is seen to be higher in 
female blood than male blood in studies two and three.  In all but one instance, a higher 
expression of SPTB was observed in the blood samples compared to saliva – the exception 
being the first study where there appeared to be more SPTB in male saliva compared to both 
male and female blood. 
 
 
 
3.2.5 Negative control amplification and melt curve analysis  
 Again, in each study negative control amplification was observed for each marker 
including 18s. 
Analysis of NTC Ct data in these studies showed that for each marker including the 
endogenous control, the NTC Ct values were more often than not, higher than the Ct values 
observed in the test samples, indicating a lower level of expression in the NTC samples.  The 
melt curve analysis data for SPTB was consistent with the melt curves observed for SPTB in 
the previous SPTB and STATH study (section 3.2.2).  Interestingly, the melt curve data for 
KRT13 in each of these studies showed that the amplification observed in the NTC and blood 
samples was more than likely due to non-specific amplification; only one peak was observed 
for these samples all exhibiting a Tm ~74°C.  The KRT13 saliva samples in all studies 
however, each exhibited two peaks; one peak at ~74°C (just like the blood and NTC) 
indicating primer-dimer artefacts, and then a main peak at ~82°C, indicating specific 
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amplification. This melt curve data supports the RQ data and specificity of KRT13 for saliva.  
In Figure 12, there was a concern regarding the higher expression levels of KRT13 in all the 
blood samples compared to saliva.  However, the melt curve data (Figure 13) suggests that 
the higher expression observed in these blood samples was due to non-specific amplification 
and that the expression (ΔCt values in Figure 12) observed in the saliva samples was due to 
amplification of the targeted sequence.      
  
Figure 13: Melt curve analysis for KRT13 in blood and saliva samples.  The lower Tm exhibited in the blood samples is 
characteristic of primer-dimer amplification.  
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 The amplification detected in the 18s NTCs in the first and second study demonstrated 
typical melt curves observed throughout previous studies in this chapter, where one peak was 
observed which peaked at the same Tm as the test samples, indicating specific amplification 
(Figure 5; section 3.1.3).  The Tm values were however slightly lower again ~78°C, a similar 
value to the 18s NTCs in the STATH and SPTB study (section 3.2.2), and as in all studies the 
NTC peaks were smaller and lower in intensity than the test samples peaks. 
In the third study however, the amplification detected in the 18s NTCs gave a 
different melt curve compared to previous studies, in that two peaks were observed and both 
theses peaks were seen to peak at different and lower Tm values to the test samples (Figure 
14), thus suggesting that the amplification in these NTCs was non-specific.  The Tm value for 
the test samples ~80°C. 
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Figure 14: Melt curve analysis for 18s in NTCs and blood and saliva samples. 
 
 
3.2.6 Reverse Transcription negative control amplification 
Amplification was detected in all 18s reverse transcription negative control samples 
(RT NTC).  The Ct values for these were higher than the Ct values observed in the test 
samples, indicating a lower level of expression, the Tm values were however ~79°C, 
suggesting that the amplification may be specific yet very low level.   The majority of all 
other RT NTC samples were negative, the odd replicate showing amplification in one or two 
samples. The Ct values of any amplified RT NTCs were never the same as the Ct values for 
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the corresponding test samples, an indication that some low level contamination may have 
occurred, most probably due to the lack of specificity of SYBR Green®, which will bind to 
any dsDNA and the ubiquitous nature of 18s rRNA. 
 
 
3.2.7 Relative quantitation and ΔCt expression of specific markers KRT4, SPTB, 
STATH and NCF2  
Figure 15: Relative expression of blood-targeted genes SPTB and NCF2 and saliva-targeted genes KRT4 and STATH in 
male and female blood and saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold 
difference. The calibrator sample in each experiment was male blood. Error bars were calculated using the RQ minimum 
and maximum data, n =  3.  
 
The results in Figure 15 were based on two separate studies investigating the 
expression of saliva-specific markers KRT4 and STATH and blood-specific markers SPTB 
and NCF2 in both male and female blood and saliva stains. 
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The results of this these studies in Figure 15 revealed a down-regulation of KRT4, and 
SPTB in all three samples compared to male blood, indicating a higher expression of these 
markers in male blood.  You would expect this for the SPTB marker given that it is blood-
specific, but not KRT4 as the latter is saliva-specific.  Overall a positive result for the SPTB 
marker with regards to the specificity.   
A down-regulation of STATH was observed in both male and female saliva samples (-
2.76 and -3.12 respectively), and an up-regulation (0.08) was seen in the female blood 
sample, compared to the male blood sample.    This suggests that more STATH is present in 
the male blood sample than both saliva samples, and even more STATH present in female 
blood compared to the male blood, both results you would not expect given that STATH is 
saliva specific. 
NCF2 was under expressed in both male and female saliva samples (-1.11 and -1.47 
respectively), and an over expression of this marker was seen in the female blood compared 
to male blood suggesting that the levels of NCF2 were higher in the female donor in this 
particular study.  This result again demonstrated good specificity for this particular marker as 
you would expect there to be less NCF2 in saliva than in blood.   
Statistical analysis demonstrated that the expression of KRT4 was significantly lower 
in male saliva compared to male blood (p ≤0.01; Table 14).  There was no significant 
difference observed for the lower expression of KRT4 in female saliva compared to female 
blood.  SPTB again however was significantly lower in male saliva compared to male blood 
(p ≤0.01), and also significantly lower in female saliva compared to female blood (p ≤0.05).  
The expression of STATH was significantly lower in male saliva compared to male blood, 
with the same result for female saliva compared to female blood (p ≤0.01).  No significant 
difference was observed for the lower expression of NCF2 in male saliva compared with male 
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blood.  The expression of NCF2 in female saliva however was significantly lower compared 
to female blood (p ≤0.01). 
 
 
Table 14: ΔCt values for blood targeted genes SPTB and NCF2, and saliva targeted genes KRT4 a nd STATH in male and 
female blood and saliva stains.  The results are mean ± SEM, n =  3, (p ≤0.05*; p ≤0.01**) 
 
Marker ΔCt Value 
 Male Blood Male Saliva Female Blood Female Saliva 
KRT4 3.99 ± 0.23 12.43 ± 0.14** 10.66 ± 0.39 12.57 ± 0.26 
SPTB 3.68 ± 0.12 12.88 ± 0.10** 9.48 ± 0.34 16.76 ± 0.39* 
STATH 10.94 ± 0.65 20.12 ± 0.54** 10.67 ± 0.25 21.32 ± 0.45** 
NCF2 8.41 ± 0.45 12.10 ± 2.10 6.36 ± 0.31 13.28 ± 0.17** 
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Figure 16: RT-PCR for blood and saliva-specific markers in male and female blood and saliva stains.  The results are mean 
± SEM, n =  3.  Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
Observation of the ΔCt values in these studies demonstrated an almost consistent 
expression pattern for each marker in female blood, with the exception of NCF2, which 
showed a slightly higher expression (Figure 16).  
The ΔCt values in the first study show that the expression of KRT4 was higher in both 
male and female saliva than SPTB, and that the expression of SPTB was higher in both male 
and female blood compared to KRT4.  Even though there appeared to be more KRT4 in the 
saliva samples than SPTB, the expression of KRT4 in both blood samples was higher than 
saliva in this study, a result you would not expect given that KRT4 is saliva-specific.  A 
higher expression of SPTB was observed in the blood samples compared to saliva in this 
study, another positive result for SPTB showing good specificity for this marker.  
The ΔCt values in the second study revealed that the expression of NCF2 was higher 
in both male and female blood samples compared to STATH, however in contrast, the 
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expression of STATH was lower in male and female saliva samples compared to NCF2.  The 
blood marker NCF2 showed good specificity in this study, as there was a higher expression of 
this marker in both blood samples than saliva.  The opposite was observed for saliva marker 
STATH, which demonstrated a higher expression in blood than saliva.  
It can be seen in both studies that there is variation in the expression levels of different 
markers between individuals.   
 
3.2.8 Negative control amplification and melt curve analysis  
Amplification was detected in all NTCs in both studies.  In the first study, the SPTB 
NTC gave a higher Ct value than all the test samples indicating a lower level of expression.  
The melt curve data for SPTB was consistent with the latter two previous results for SPTB 
(Section 3.2.2 and 3.2.5) where one peak was observed rather than two and the Tm values 
were the same also.   
The KRT4 NTC sample demonstrated a higher Ct value than both the male and 
female saliva test samples, indicating a lower expression in this NTC sample compare to 
saliva.  In comparison to both the blood test samples the KRT4 NTC Ct value was very 
similar.  Analysis of the melt curve data showed the same melting characteristics as previous 
KRT4 melt curves (Figure 5; Section 3.1.3).  The data confirmed that the amplification 
observed in the KRT4 blood and NTC samples were non-specific, as both of these samples 
exhibited a small peak/hump to the left with a low Tm value, typical characteristics of primer-
dimer artefacts.  The main melting peak for KRT4 in saliva however was again much larger 
and exhibited a higher Tm value, suggesting that the amplification in this sample was specific 
to KRT4.  Previous analysis of the ΔCt values in Figure 16 showed a higher expression of 
KRT4 in blood compared with saliva, casting doubt on the specificity of this marker.  
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However, the melt curve data suggests this was more than likely due to non-specific 
amplification; this information, coupled with the RQ data thus shows good marker specificity.  
In the second study, the melt curve data for NCF2 demonstrated that specific 
amplification occurred in the NTCs, as peaks for these samples peaked at the same Tm value 
as the test samples ~82 °C, smaller peaks/humps were also observed an indication of primer-
dimers.  This amplification may be the result of low level contamination or possibly due to 
the high number of PCR cycles coupled with the background fluorescence of SYBR® Green 
dye. 
Just as in previous studies, the melt curve data for the STATH NTCs demonstrated 
that the peak for these samples peaked at the same Tm as the test samples, which all exhibited 
a low Tm ~68°C, characteristic of primer-dimer artefacts, thus indicating non-specific 
amplification in these samples.  
In all cases, the 18s NTCs demonstrated a higher Ct value than the test samples, 
indicating a lower level of expression.  The melt curve data in each study was similar to that 
observed in Figure 16; Section 3.2.5, where two peaks were observed, both of which peaked 
at a different Tm value to the test samples, thus suggesting that the amplification observed in 
these NTCs was non-specific.  The Tm value for the test samples was consistent with all other 
studies ~80°C. 
 
3.2.9 Reverse Transcription negative control amplification 
In the first study, amplification was detected in the male blood 18s RT NTC sample 
and the female saliva 18s RT NTC, the other 18s RT NTCs (male saliva and female blood) 
were negative.    
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The Ct values for both the male blood and female saliva 18s RT NTCs were much 
higher than the Ct values observed in the corresponding test samples, thus indicating low 
level specific amplification may have occurred in these samples due to the lack of specificity 
of SYBR Green®.  The melt curves for these samples also suggested specific amplification, 
with both peaks peaking at the same Tm as the test samples but at a lower intensity.  All other 
RT NTC samples for markers SPTB and KRT4 were negative.   
In the second study, amplification was seen in all the RT NTCs, and the Ct values 
were very similar to those observed in the corresponding test samples.  Thus, casting doubt on 
the specificity of amplification observed in the NCF2 samples.  It has already been 
established that STATH in this study did not appear to work; however the fact that similar 
amplification was observed in the RT NTCs for NCF2 as in the test samples suggests that the 
amplification may not have been mRNA and could possibly be DNA.  Again a disadvantage 
of using SYBR Green dye is that will bind to any genomic DNA (gDNA) present in a sample, 
sometimes making it difficult to distinguish whether or not the amplification/ detected 
fluorescence is due to the targeted sequence of non-specific amplification. 
 
3.2.10 Relative quantitation and ΔCt expression of specific markers NCF2, HTN3, 
KRT4 and SPRR1A 
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Figure 17: Relative expression of blood-targeted gene NCF2 and saliva-targeted genes HTN3, KRT4 and SPRR1A in male 
and female blood and saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold 
difference, the formula used to create the gene expression plot was 2-ΔΔCT and the calibrator sample in each experiment was 
male blood.  The error bars were calculated using the RQ minimum and maximum data, n =  3. 
 
The results in figure 17 were based on one study investigating the expression of 
saliva-specific markers HTN3, KRT4 and SPRR1A and blood-specific marker NCF2 in both 
male and female blood and saliva stains. 
The results revealed a down regulation for HTN3 (-1.63 and -1.88) and KRT4 (-1.90 
and -2.05) in both male and female saliva samples, indicating a higher expression of these 
markers in the male blood sample.  An up-regulation of SPRR1A was observed in both male 
and female saliva samples (1.49 and 1.40 respectively); indicating a lower expression of this 
saliva marker in male blood, and a down regulation of NCF2 was observed in the female 
saliva sample (-0.86), indicating a higher expression of this marker in male blood.  
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Expression of NCF2 in male saliva did occur however the expression was so small (-
0.01) that it could not be observed in the expression plot, this result supporting the specificity 
of NCF2 for blood. 
Statistical analysis demonstrated that the expression of NCF2 was significantly lower 
in female saliva compared to female blood (p ≤0.05; Table 17).  However, no significant 
difference was observed for the lower expression of NCF2 in male saliva compared with male 
blood.  HTN3 was significantly lower in male saliva compared to male blood (p ≤0.05), and 
again in female saliva compared to female blood (p ≤0.01).  KRT4 was also significantly 
lower in male saliva compared with male blood (p ≤0.01), and the again the same in female 
saliva and blood (p ≤0.05).  There was no significant difference observed for the higher 
expression of SPRR1A in male saliva compared with male blood, however a significant 
difference was seen in the higher expression of SPRR1A in female saliva compared with 
female blood, in figure 17 a slight up-regulation was observed for SPRR1A in female blood.   
 
 
 
Table 15: ΔCt values for blood targeted gene NCF2, and saliva targeted genes KRT4 and SPRR1A in male and female blood 
and saliva stains.  The results are mean ± SEM, n =  3, (p ≤0.05*; p ≤0.01**).   
 
Marker ΔCt Value 
 Male Blood Male Saliva Female Blood Female Saliva 
NCF2 10.05 ± 0.24 10.08 ± 0.19 7.76 ± 0.71 12.92 ± 0.15* 
HTN3 9.97 ± 0.75 15.38 ± 0.69* 6.69 ± 0.38 16.23 ± 0.90** 
KRT4 9.11 ± 0.86 15.43 ± 0.23** 5.34 ± 0.48 15.92 ± 0.85* 
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SPRR1A 11.10 ± 1.79 6.14 ± 0.06 10.84 ± 0.13 6.43 ± 0.04** 
 
 
Figure 18: RT-PCR for blood and saliva-specific markers in male and female blood and saliva stains.  The results are mean 
± SEM, n =  3.  Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
Observation of the ΔCt values demonstrated a higher expression of NCF2 in the 
female blood sample compared to both the male and female saliva samples; however there 
appears to be the same expression of NCF2 in male blood as there is in male saliva. 
Unexpectedly, a higher expression of HTN3 was observed in both blood samples 
compared to saliva, there even appeared to be more HTN3 in blood than NCF2.  A similar 
expression of HTN3 was observed in male and female saliva samples, with the male sample 
showing the highest expression. 
A higher expression of saliva-specific marker KRT4 according to the ΔCt values in 
Figure 19 was observed in both blood samples compared to saliva, again a result you would 
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not expect given that KRT4 is saliva specific.  The expression of KRT4 in blood was also 
higher than the blood-specific marker NCF2 which you would not expect.  The expression 
levels of KRT4 in male and female saliva were quite similar, again the male saliva sample 
showing a slightly higher expression, this result showing levels of expression of KRT4 can 
vary between individuals.  In comparison to the saliva-specific marker HTN3, there appeared 
to be more KRT4 present in all samples, and unexpectedly, a higher expression of NCF2 in 
both male and female saliva was observed compared to both these markers. 
A higher expression of SPRR1A was observed in both saliva samples compared to 
blood.  A positive result for this marker given that it is saliva specific and you would expect 
the expression to be higher in saliva than in blood.  There even appeared to be more SPRR1A 
marker in saliva compared to the blood marker NCF2, and also less SPRR1A in blood than 
NCF2.  The expression of SPRR1A was much higher in saliva compared to the HTN3 and 
KRT4. 
 
3.2.11 Negative control amplification and melt curve analysis  
Amplification was detected in all the NTCs in this study.  The Ct value observed for 
the NCF2 NTC sample was similar to the Ct value observed in the male saliva test sample, 
but lower than the Ct values for the other three test samples, indicating a slightly higher 
expression level in the NTC sample compared to male blood, female blood and female saliva.  
Interestingly, the melt curve data for NCF2 differed to previous studies (Section 3.1.3 and 
3.2.8); two peaks were observed for the NTC, the main Tm value being ~82°C and the lower 
Tm value being ~75°C, indication of specific amplification and primer-dimer artefacts.  For 
both the male and female blood samples, one peak was observed ~76°C, and for male and 
female saliva one peak was observed at ~82 °C.  This result is therefore suggesting that in this 
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case the targeted amplicon was observed in saliva rather than blood, which you would not 
expect given that NCF2 is blood specific, and that specific amplification was observed in the 
NTC sample. 
  The Ct values observed for the HTN3 and KRT4 NTC samples were both lower than 
their corresponding test samples, indicating a slightly higher level of expression in the NTCs.  
The melt curve data for HTN3 demonstrated that the NTC sample peaked at the same Tm 
value as the test samples, and that these peaks had a Tm value of ~70°C, so therefore are more 
than likely due to non-specific amplification, possibly due to primer-dimer formation.  This 
result is suggestive that HTN3 may have failed to work in this study.  The melt curve data for 
KRT4 demonstrated that the peak observed in the NTC had a Tm value of ~73°C.  This was 
the same Tm value observed in the male and female blood samples and the female saliva 
sample.  For the male saliva sample, two peaks were observed, the main peak having a Tm 
value ~73°C, and a smaller peak to the right exhibiting a Tm value of ~82°C.  This Tm value 
is almost the same as the Tm value observed for KRT4 in saliva in Figure 5, Section 3.1.3.  
However in this particular study, the peak with the larger Tm that corresponds to the targeted 
amplicon is much smaller and lower in intensity, indicating that the amplification of the 
targeted amplicon in this case may have been lower than the amplification of primer-dimers, 
this could explain why no second peak was observed in the female KRT4 saliva sample.  
For the SPRR1A NTC sample however, a very high Ct value was observed ~44, this v 
value is extremely close to the Ct max value 45 (where Ct max is the maximum number of 
PCR cycles), and is indication of very very low levels of expression.  This Ct value was 
closer to Ct observed in the blood samples, in particular the female blood sample, but much 
higher than the Ct values observed in the saliva samples, thus supporting the specificity of 
this saliva marker.  Analysis of the melt curve data showed that the peak for the SPRR1A 
NTC sample was small/low intensity, and exhibited a low Tm value of ~ 68°C, characteristic 
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of primer-dimer formation.  The test samples; male saliva and female saliva both exhibited 
two peaks, a smaller peak with a lower Tm value similar to the NTC, and a much a larger peak 
with a higher Tm value ~79°C, suggesting that the amplification in these samples was due the 
targeted amplicon and specific to SPRR1A.  The male and female blood test samples 
however, demonstrated one peak rather than two - similar to that of the NTC, an indication 
that the amplification in these samples was non-specific (Figure 19) 
 
Figure 19: Melt curve analysis for saliva-specific SPRR1A in the negative control, blood and saliva samples. 
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In all cases, the 18s NTCs again demonstrated a higher Ct value than the test samples, 
indicating a lower level of expression.  The melt curve data in this study was similar to that 
observed in Figure 16. Section 3.2.5, where two peaks were observed for the 18s NTC 
sample, both of which peaked at a different Tm value to the test samples, thus suggesting that 
the amplification observed in these NTCs was non-specific.  The Tm value for the test 
samples was consistent with all other studies ~80°C (Figure 20) 
 
Figure 20: Melt curve analysis for 18s in the negative control and test samples 
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3.2.12 Reverse Transcription negative control amplification 
Amplification was detected in the representative RT NTC samples, and analysis of the 
Ct values demonstrated that all the RT NTCs were similar to the corresponding test samples, 
again casting doubt on the amplification observed in the test samples.  The melt curve data for 
these RT NTC samples also showed similar peaks to those observed in the test samples. 
 
3.2.13 Relative quantitation and ΔCt expression of specific markers NCF2, SPTB, KRT4 
and SPRR1A 
 
Figure 21: Relative expression of blood-targeted genes SPTB and NCF2 and saliva-targeted genes KRT4 and SPRR1A in 
male and female blood and saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold 
difference.  The calibrator sample in each experiment was male blood.  Error bars were calculated using the RQ minimum 
and maximum data, n =  3. 
 
The results in figure 21 were based on one study investigating the expression of 
saliva-specific markers KRT4 and SPRR1A and blood-specific markers SPTB and NCF2 in 
both male and female blood and saliva stains. 
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A down-regulation of blood markers SPTB and NCF2 was observed in both the male 
and female saliva samples, indicating a higher expression of these markers in blood.  An up-
regulation of saliva markers KRT4 and SPRR1A was observed in both male and female 
saliva samples, indicating a higher expression of these markers in saliva.   
This result therefore shows good specificity for each marker in this study, where the 
blood markers were more present in blood and the saliva markers were more present in saliva.  
Statistical analysis demonstrated that there was no significant difference observed in 
the lower expression of SPTB in either the male or female saliva sample compared with the 
corresponding blood samples. The under expression of NCF2 in male saliva compared to 
male blood was also not significant.  In female saliva however, a significant difference was 
observed in the lower expression of NCF2 in this sample compared with female blood (p 
≤0.01; Table 16). The higher expression of KRT4 in male saliva compared with male blood 
was significantly different (p ≤0.01), this was also the case for the higher expression of KRT4 
in female saliva compared with female blood.  SPRR1A was significantly higher in male 
saliva compared with male blood (p ≤0.01), however no significant difference was observed 
in the higher expression of this marker in female saliva compared with female blood. 
 
Table 16: ΔCt values for blood targeted genes SPTB and NCF2, and saliva targeted genes KRT4 and SPRR1A in male and 
female blood and saliva stains.  The results are mean ± SEM, n =  3, (p ≤0.05*; p ≤0.01**).  Result highlighted in red n= 1. 
 
Marker ΔCt Value 
 Male Blood Male Saliva Female Blood Female Saliva 
SPTB 24.35 ± 0.54 26.55 ± 0.59 19.75 ± 1.24 25.42 ± 2.20 
NCF2 19.52 ± 0.20 19.71 ± 0.76 17.12 ± 0.02 21.84 ± 0.50** 
KRT4 22.19 ± 0.21 18.55 ± 0.66** 16.07 ± 0.18 20.67 ± 0.66** 
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SPRR1A 23.46 ± 0.31 18.57 ± 0.26** 16.39 ± 0.00 20.02 ± 0.32 
 
 
  
Figure 22: qRT-PCR for blood and saliva-specific markers in male and female blood and saliva stains.  The results are mean 
± SEM, n =  3 (except SPRR1A in female blood where n= 1).  Low ΔCt values correspond to a high expression level of the 
specific mRNA.   
 
Observation of the ΔCt values demonstrated a higher expression of SPTB in female 
blood compared to male blood, there was also more SPTB present in blood than in saliva 
(Figure 22), indicating good specificity for this marker.  
A higher expression of NCF2 was observed in both blood samples compared to saliva; 
however the expression observed in male blood was only slightly lower than the male saliva 
sample.  These results also show that there was more NCF2 in both blood samples compared 
to SPTB.  
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Analysis of the ΔCt values for KRT4 demonstrates that the expression of this marker 
is higher in female blood than both male and female saliva samples, a result you would not 
expect given that this marker is saliva specific.  The expression of this marker in male blood 
was lower than all samples, this sample therefore showing good marker specificity. 
According to these results there was more KRT4 present in female blood than both NCF2 and 
SPTB, and more KRT4 present in male blood than SPTB.  Again the latter result you would 
not expect given that KRT4 is saliva specific.  Analysis of the melt curve data will suggest 
whether or not this amplification is specific.  The expression of KRT4 in both saliva samples 
was similar, again a slightly higher expression was observed in the male saliva sample.   
The ΔCt values for SPRR1A were almost identical to that of KRT4 (Figure 22), 
expression of SPRR1A was higher in both saliva samples compared to the calibrator sample 
male blood; a result you would expect given SPRR1A is saliva-specific.  However, Figure 22 
shows that the expression levels of SPRR1A were higher in female blood compared to both 
the male and female saliva samples – melting curve analysis will suggest whether or not this 
amplification is specific.  The expression levels of SPRR1A in both saliva samples were 
similar, the higher expression again observed in male saliva. 
 
3.2.14 Negative control amplification and melt curve analysis  
 Amplification was observed in all the NTC samples.  The Ct value for the SPTB NTC 
sample was lower than all the corresponding test samples but not by much.  The melt curve 
data for SPTB was again consistent with previous studies for SPTB (Section 3.2.2, 3.2.5, and 
3.2.8), where one peak was observed rather than two, and the Tm values were the same also, 
with exception for one replicate in the male SPTB blood sample that showed a peak at ~80°C. 
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 The Ct value for the NCF2 NTC sample was similar to both the male blood and saliva 
samples, but lower than the values obtained for the female blood and saliva samples.  In this 
study, the melt curve data for the NCF2 NTC samples showed a large peak at ~83°C.  The 
test samples all showed two peaks, the smaller peaks exhibiting a lower Tm and the larger 
peaks exhibiting higher Tm value ~80°C, suggesting that this amplification observed in the 
test samples was due to the targeted amplicon and the smaller peaks are probably due to 
primer-dimer artefacts.  The fact that the NCF2 NTC sample exhibited one main peak at such 
a high Tm value suggests that this amplification is more than likely due to specific 
amplification too, thus indicating low level contamination may have occurred.  
The Ct value for the KRT4 NTC sample gave a similar value to the male blood 
sample and both the female blood and saliva sample.  The male saliva Ct value in this study 
however was much higher indicating a lower level of expression.  Analysis of the melt curve 
data demonstrated that the KRT4 NTC sample exhibted a peak with a Tm value ~72°C, this 
was also the case for male and female blood KRT4 test samples.  In the KRT4 saliva samples 
for both male and female two peaks were observed, the smaller peak consistent with the Tm 
values observed for the NTC and blood samples, and a larger peak that exhibited a higher Tm 
value ~80°C.  This value was again very similar to the Tm values observed in previous melt 
curves for KRT4 in saliva (Figure 5, Section 3.1.3).  This result therefore suggests that the 
amplification observed in the NTC and blood samples was non-specific, and that the 
amplification observed in the saliva samples was as result of specific amplification for the 
saliva marker KRT4, thus showing good specificity for this marker.  In Figure 22, the ΔCt 
values indicated there to be more KRT4 in the female blood sample compared to both saliva 
samples, the melt curve data shows that the amplification observed in those blood samples 
was a result of non-specific amplification. 
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 Analysis of the Ct value for SPRR1A NTC demonstrated that this value was similar 
to the Ct values observed in both the male and female blood samples, and that both saliva 
samples exhibited a lower Ct value, indicating a higher level of expression in both these test 
samples compared to the blood and NTCs.  This result supports the specificity of this marker, 
as you would expect the expression of SPRR1A to be higher in saliva than in blood, it 
suggests that the amplification observed in blood could be the same as the NTC and may be 
non-specific.  The melt curve data was almost identical to Figure 19, Section 3.2.11, where 
two peaks were observed for the saliva samples and one peak was observed for the NTC and 
blood samples.  The Tm values for each sample were also very similar, thus suggesting that 
specific amplification occurred in the saliva samples for SPRR1A, and that the amplification 
observed in the NTC and blood samples was more than likely non-specific amplification. 
Again, the 18s NTC sample demonstrated a much higher Ct value than the test 
samples, indicating a very lower level of expression.  The melt curve data for the 18s NTCs in 
this study was again similar to Figure 14, Section 3.2.5 and Figure 20, Section 3.2.11, where 
two peaks were observed for the NTC, both of which peaked at a different Tm value to the test 
samples, thus suggesting that the amplification observed in these NTCs was non-specific.  
The Tm value for the test samples was consistent with all other studies ~80°C. 
 
3.2.15 Reverse Transcription negative control amplification 
Amplification was detected in the representative RT NTC samples.  The Ct values for 
the male blood SPTB RT NTC and female blood NCF2 RT NTC were similar to their 
corresponding test samples, indicating the same level of expression in both the test and RT 
NTC samples.  The Ct values for the male saliva KRT4 RT NTC and female saliva SPRR1A 
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RT NTC were higher than their corresponding tests samples, thus indicating a lower level of 
expression in the RT NTCs. 
Analysis of the melt curve data demonstrated that the peak for the male blood SPTB 
RT NTC sample peaked at the same Tm as the corresponding test sample.   The melt curve 
data for the male saliva KRT4 RT NTC sample demonstrated one peak that was consistent 
with the smaller peak in the KRT4 male saliva sample i.e. primer-dimer artefacts, no second 
peak was observed therefore indicating that the amplification observed in this RT NTC 
sample was non-specific.  The melting peak observed for the female blood NCF2 RT NTC 
sample also demonstrated one peak that peaked at the same Tm value as the smaller peak in 
the female blood NCF2 test sample.  There was also no second peak in this RT NTC sample, 
thus indicating that the amplification was non-specific.  Analysis of the melt curve for the 
female saliva SPRR1A RT NTC sample demonstrated one peak which corresponded to the 
smaller peak observed in the corresponding test sample.  Thus indicating that this RT NTC 
was non-specific (Figure 23). 
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Figure 23: Melt curve analysis of the female saliva SPRR1A RT NTC sample compared to the female saliva SPRR1A test 
sample 
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3.2.16 Expression of endogenous control 18s rRNA in blood and saliva stains. 
 
Table 17: Raw Ct values for endogenous control 18s rRNA in male and female blood and saliva stains.  Results are mean ± 
SEM, n =  3, (p ≤ 0.01**). The data highlighted red indicates zero significant difference indicating equal expression of 18s 
rRNA.   
 
Study 18s rRNA Ct value 
 Male Blood Male Saliva Female Blood Female Saliva 
1 27.03 ± 0.66 15.92 ± 0.02** 24.12 ± 0.15 17.42 ± 0.11** 
2 26.82 ± 0.06 17.29 ± 0.10** 21.35 ± 0.41 12.90 ± 0.05** 
3 16.16 ± 0.21 16.90 ± 0.07 18.60 ± 0.32 12.54 ± 0.13** 
4 17.09 ± 0.44 11.39 ± 0.98** 18.00 ± 0.21 11.17 ± 0.08** 
5 26.39 ± 0.09 14.12 ± 0.09** 26.64 ± 0.09 20.56 ± 0.02** 
6 24.96 ± 0.10 15.54 ± 0.07** 19.54 ± 0.30 11.44 ± 0.20** 
7 26.30 ± 0.27 15.83 ± 0.05** 28.12 ± 0.08 19.87 ± 0.04** 
8 25.48 ± 0.0.17 18.28 ± 0.04** 29.12 ± 0.13 18.25 ± 0.01** 
9 10.42 ± 0.13 7.87 ± 0.25** 15.78 ± 0.02 10.06 ± 0.10** 
 
 
 As mentioned earlier in this chapter (Section 3.1.2, an ideal endogenous control 
should be expressed at a constant level in different tissues, and in each study throughout this 
chapter, this has not been the case.   
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3.3 A quantitative comparison of blood and saliva specific markers in blood and 
saliva stains utilising Taqman® hydrolysis probes and 18s rRNA endogenous 
control. 
3.3.1 Relative quantitation and ΔCt expression of blood and saliva specific markers  
 
Figure 24: Relative expression of blood-targeted genes NCF2 and SPTB, and saliva-targeted genes STATH, HTN3, KRT4 
and KRT13 in male blood and saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold 
difference. The calibrator sample in each experiment was male blood.  Error bars were calculated using the RQ minimum 
and maximum data, n =  3.   
 
The results in Figure 24 were based on one study investigating the expression of 
saliva-specific markers KRT4, KRT13, STATH and HTN3 and blood-specific markers SPTB 
and NCF2 in both male and female blood and saliva stains, this time using Taqman® Gene 
Expression Assays rather than SYBR® Green dye. 
A down-regulation was observed for NCF2 (-0.85) in the saliva sample compared to 
blood, indicating a higher expression in blood than saliva.  A down-regulation was also 
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observed for saliva specific markers STATH (-2.45) and HTN3 (-4.23) in saliva compared to 
blood. 
In Figure 24, there is no RQ data for markers SPTB, KRT4 and KRT13; this was due 
to amplification occurring in one sample and not the other, preventing a comparative analysis.  
As a result, the data for these markers was expressed as ΔCt and is shown in Table 18 and 
Figure 25.  
Statistical analysis demonstrated that the expression of NCF2 was significantly higher 
in blood than saliva (p ≤ 0.01; Table 15).  Statistical comparison for other markers between 
body fluids was not possible, due to the fact that these markers were mainly detected in one 
body fluid over the other.  However, the absence of amplification and the inability to do a 
comparative analysis does not negate a result; an absent result alone could be meaningful.  
For example in Table 15, the saliva specific markers KRT4 and KRT13 showed zero 
detectable amplification in the male blood samples compared to saliva, a result you would 
expect given that these markers are specific to saliva.  Amplification did occur for STATH 
and HTN3 in the male blood samples however only one replicate showed detectable 
amplification, the other two replicates showed zero amplification, whereas in the male saliva 
samples, all replicates showed amplification for these markers.  Zero amplification was 
detected for blood marker SPTB in male saliva, yet the result for SPTB in blood was based on 
one replicate showing detectable amplification, decreasing the value of this particular result. 
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Table 18: ΔCt values for blood targeted genes NCF2 and SPTB, and saliva targeted genes KRT4, KRT13, STATH and HTN3 
in male blood and saliva stains.  The results are mean ± SEM, n =  3.  Zero values correspond to no expression of target. 
Data highlighted red is based on amplification occurring in one replicate, (p ≤ 0.01**). 
 
  Marker ΔCt value  
 Male Blood Male Saliva 
NCF2 12.20 ± 0.67 15.03 ± 0.40** 
SPTB  17.67 0.00 
KRT4 0.00 15.13 ± 0.08 
KRT13 0.00 12.20 ± 0.08 
STATH 4.54 12.68 ± 0.10 
HTN3 3.09 17.14 ± 0.23 
 
 
Figure 25: qRT-PCR for blood and saliva-specific markers in male blood and saliva stains.  The results are mean ± SEM, n 
=  3 (except in cases where n <  3). Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
 Analysis of the ΔCt values in Figure 25 demonstrated that the blood-specific marker 
NCF2 was expressed in both blood and saliva, and that a higher expression was observed in 
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the blood sample, showing good specificity for this marker.  Expression of the blood-specific 
marker SPTB was also observed in blood and not saliva, however this data was based on one 
out of three replicates showing amplification.  Saliva-specific markers KRT4 and KRT13 
were both expressed in saliva and not blood, thus both markers showing very good specificity 
to saliva – in this study there appeared to be more KRT13 present in saliva than KRT4.  For 
the other saliva markers; STATH and HTN3, the ΔCt values show a higher expression was 
observed in blood than saliva, however this data is inaccurate as it was based on one out of 
three replicates showing detectable amplification.  Amplification of these markers in the 
saliva samples however occurred in all replicates, thus from this data it can be suggested that 
STATH and HTN3 are more specific to saliva than blood.    
 
 
 
110 
 
3.3.2 Relative quantitation and ΔCt expression of blood and saliva specific markers  
Figure 26: Relative expression of blood-targeted genes NCF2 and SPTB, and saliva-targeted genes KRT13, HTN3, STATH 
and KRT4 in male and female blood and saliva stains. The results were normalised to reference gene 18s rRNA and 
expressed as a fold difference.  The calibrator sample in each experiment was female blood.  Error bars were calculated 
using the RQ minimum and maximum data, n =  3.   
 
The results in Figure 26 were based on one study investigating the expression of 
saliva-specific markers KRT4, KRT13, STATH and HTN3 and blood-specific markers SPTB 
and NCF2 in both male and female blood and saliva stains, this time using Taqman® Gene 
Expression Assays. 
 A down-regulation was observed for blood-specific markers NCF2 (-1.59) and SPTB 
(-1.75) in female saliva, indicating a higher expression of these markers in female blood, 
NCF2 was also under expressed in male saliva (-0.55) compared to female blood,   no 
expression for SPTB was observed in the male saliva sample.  These results all show good 
specificity for both blood markers.  An up-regulation was observed for saliva-specific 
markers KRT4 and HTN3 in both male and female saliva samples (4.02, 0.97, 3.32 and 1.60 
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respectively), indicating a lower expression of these markers in the female blood sample.  No 
expression data was observed in the RQ gene expression plot for markers STATH and KRT4.  
This was due to amplification occurring one sample rather than the both, therefore a relative 
comparison could not be made.  The amplification for these saliva markers was expressed as 
ΔCt instead (Figure 27), and the results are listed in Table 17.  For both of these saliva 
markers, zero amplification was detected in both male and female blood samples, showing 
good marker specificity.   
In both male and female samples, statistical analysis demonstrated that the expression 
of NCF2 was significantly higher in blood than saliva (p ≤ 0.05; Table 19).  There was 
however, no significant difference in the expression of HTN3 in both male and female blood 
and saliva samples.  For all other markers a statistical difference between body fluids could 
not be established as amplification mainly occurred in one body fluid, this absence of data 
again does not negate the result, and is in fact meaningful with regards to the specificity of 
these markers.    
 
Table 19: ΔCt values for blood targeted genes NCF2 and SPTB, and saliva targeted genes KRT4, KRT13, STATH and HTN3 
in male and female blood and saliva stains.  The results are mean ± SEM, n =  3. Zero values correspond to no expression of 
target. Data highlighted red is based on amplification occurring in one replicate, (p ≤ 0.05*; p ≤ 0.01**) 
 
Marker ΔCt value 
 Male Blood Male Saliva Female Blood Female Saliva 
NCF2 14.28 ± 0.17 16.37 ± 0.28* 14.55 ± 0.04 19.82 ± 0.08** 
SPTB  0.00 0.00 17.50 ± 0.48 23.31 
KRT4 0.00 10.97 ± 0.02 0.00 10.75 ± 0.01 
KRT13 0.00 7.45 ± 0.01 18.50 5.15 ± 0.03 
STATH 0.00 14.69 ± 0.14 0.00 16.43 ± 0.05 
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HTN3 16.25 ± 0.40 11.66 ± 0.14 16.98 ± 1.78 13.74 ± 0.21 
 
 
Figure 27: qRT-PCR for blood and saliva-specific markers in male blood and saliva stains.  Results are mean ± SEM, n =  3 
(except in cases where n <  3). Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
 The ΔCt values in Figure 27 demonstrate that the expression of NCF2 was again 
higher in both male and female blood samples compared to saliva, just like previous results, 
therefore showing good specificity for this marker.  SPTB was also higher in female blood 
than female saliva – the ΔCt value for the latter sample being higher than the blood, and based 
on one replicate showing amplification, thus showing good marker specificity.  SPTB was not 
present in the male blood sample in this particular study, which you would expect given that 
SPTB is blood-specific, but this result is similar to the result in section 3.3.1, where only one 
replicate showed amplification for SPTB in the male blood sample and zero amplification 
occurred in the male saliva sample.  It may be that SPTB was expressed higher in the female 
donor sample in this study.  
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 Just as in the previous study, good specificity was shown for saliva marker KRT4, 
where zero amplification was detected in either the male or female blood samples but 
expression occurred in both the male and female saliva samples.  The expression levels in 
these latter samples were also quite similar to one another, with female blood showing a 
slightly higher expression (Figure 27). 
 KRT13 was shown again to be saliva specific, the ΔCt values demonstrate a higher 
expression of this marker in both male and female saliva compared to blood, the highest 
expression observed in female saliva.  No amplification was detected in the male blood 
sample for KRT13.  This was a very positive result with regards to the specificity of this 
marker, as the zero amplification indicates an absence of KRT13 in that particular blood 
sample.  The ΔCt value observed for KRT13 in female blood, which was higher than those 
observed in saliva, was based on one replicate showing amplification, the result therefore 
indicates a very low level expression of KRT13 in this female blood. 
 The ΔCt values for STATH were very similar in both the male and female saliva 
samples, with the male sample showing a slightly higher expression.  Zero amplification was 
detected in either the male or female blood samples, showing excellent marker specificity for 
STATH given that it is saliva-specific.  
 Lastly, a higher expression of HTN3 was observed in both the male and female saliva 
samples than blood.  The expression levels were again quite similar with the higher 
expression observed in male saliva.  Even though statistical analysis showed there was no 
significant difference in the expression of HTN3 in saliva compared to blood, the results in 
figure 27 at least support the specificity of this marker. 
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3.3.3 Relative quantitation and ΔCt expression of blood and saliva specific markers  
 
Figure 28: Relative expression of blood-targeted genes NCF2 and SPTB, and saliva-targeted genes KRT4, KRT13 and HTN3 
in female blood and saliva stains. The results were normalised to reference gene 18s rRNA and expressed as a fold 
difference.  The calibrator sample in each experiment was female blood. Error bars were calculated using the RQ minimum 
and maximum data, n =  3.   
 
 The results in Figure 28 were based on one study, again repeating the 
investigation of the expression of saliva-specific markers KRT4, KRT13, STATH and HTN3 
and blood-specific markers SPTB and NCF2 in both male and female blood and saliva stains, 
this time using Taqman® Gene Expression Assays. 
Just as in previous results, a down-regulation was observed for NCF2 (-1.43) in saliva 
compared to blood, and an up-regulation of KRT4 (1.96) and KRT13 (1.89) was observed in 
saliva compared to blood, these results therefore showing good specificity for these markers.  
In contrast to previous results, a down-regulation was observed for HTN3 in saliva (-6.73), 
-8.00
-6.00
-4.00
-2.00
0.00
2.00
4.00
6.00
8.00
Female Blood Female Saliva
Lo
g
1
0
R
Q
 
Sample 
NCF2
KRT4
KRT13
HTN3
SPTB
STATH
115 
 
this result suggesting that there was more HTN3 present in blood.  However having observed 
the raw ΔCt values for this data, it was discovered that the amplification observed in the blood 
sample for HTN3 was based on one replicate rather than three (Table 20 and Figure 29), thus 
skewing the data in the plot. 
For markers STATH and SPTB, no expression data was observed in the RQ gene 
expression plot (Figure 28).  This was due to amplification occurring in one sample rather 
than both, therefore a relative comparison could not be made.  The amplification for these 
markers was expressed as ΔCt instead (Figure 30), and the results are listed in Table 20.   
Statistical analysis demonstrated that the expression of NCF2 was significantly higher 
in blood than in saliva (p ≤0.01**).  The expression of KRT4 and KRT13 was also 
significantly higher in saliva than in blood (p ≤0.01**).  For all other markers a statistical 
difference between body fluids could not be established as amplification mainly occurred in 
one body fluid, this absence of data again does not negate the result, and is in fact meaningful 
with regards to the specificity of these markers.   Markers SPTB and STATH show excellent 
specificity in Table 18, as zero amplification was detected in saliva for SPTB and in blood for 
STATH.  The ΔCt result for SPTB in female blood is consistent with the previous results in 
Section 3.3.2. 
Table 20: ΔCt values for blood targeted genes NCF2 and SPTB, and saliva targeted genes KRT4, KRT13 and HTN3 in 
female blood and saliva stains.  The results are mean ± SEM, n =  3.  Zero values correspond to no expression of target. Data 
highlighted red is based on amplification occurring in one replicate, (p ≤ 0.01**) 
 
Marker ΔCt value  
 Female Blood Female Saliva 
NCF2 16.17 ± 0.37 20.92 ± 0.17** 
SPTB  18.56 ± 0.12 0.00 
KRT4 17.55 ± 0.60 11.04 ± 0.03** 
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KRT13 15.49 ± 0.15 9.22 ± 0.04** 
STATH 0.00 17.15 ± 0.03 
HTN3 -9.75 12.61 ± 0.09 
 
Figure 29: RT-PCR for blood and saliva-specific markers in male blood and saliva stains.  Results are mean ± SEM, n =  3 
(except in cases where n <  3). Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
Observation of the ΔCt values demonstrated that NCF2 was again higher in blood than 
saliva, and that SPTB was only expressed in blood – showing very good marker specificity.  
Note that SPTB was not detected in the male samples in previous experiments but was 
detected in all replicates in the female blood sample in this study and the previous study. 
The results for saliva specific markers KRT4 and KRT13 in this study differ from the 
two previous TaqMan® studies (Section 3.3.1 and 3.3.2).  Previously, these markers either 
demonstrated zero amplification in blood, or amplification in just one replicate (KRT13 in 
female blood).  In this particular study, KRT4 and KRT13 show detectable amplification in 
the female blood samples amplifying in all three replicates (Table 20).  Thus, indicating that 
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the levels of these markers can vary in individuals at different times. The expression levels of 
KRT4 and KRT13 in these blood samples however, were still lower than the expression 
levels observed in saliva, indicating a higher expression in saliva, therefore supporting the 
specificity of these saliva-specific markers.  
Good marker specificity was observed for STATH in this study also, as STATH was 
only expressed in saliva and not blood (Table 20) 
Lastly, the ΔCt values for saliva-specific marker HTN3 demonstrated a higher 
expression in blood than saliva, thus showing decreased specificity for this marker.  However, 
as mentioned previously, the ΔCt value for HTN3 in blood was based on one replicate 
showing amplification, whereas all replicates showed amplification in saliva, thus the latter 
may be a truer reading and thus support the specificity of the marker. 
  
3.3.4 Expression of endogenous control 18s rRNA in blood and saliva stains. 
Just as in previous SYBR® Green studies, the expression levels of eukaryotic 18s 
rRNA endogenous control in these studies was different in blood and saliva.  Statistical 
analysis demonstrated that 18s rRNA in each study was again significantly higher in saliva 
than in blood (p ≤0.01**; Table 21).  A low Ct value corresponds to a higher expression level 
of the target.   
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Table 21: Raw Ct values for endogenous control 18s rRNA in male and female blood and saliva stains.  Results are mean ± 
SEM, n =  3, N/A corresponds to samples that were not investigated in that particular study.  A low Ct value corresponds to a 
higher expression of the endogenous control, (p ≤ 0.01**).   
 
Study 
18s rRNA Tm value 
18s rRNA Tm  value  (°C) 
 Male Blood Male Saliva Female Blood Female Saliva 
1 19.39 ± 0.03 16.76 ± 0.07** N/A N/A 
2 21.08 ± 0.01 18.96 ± 0.00** 18.51 ± 0.02 14.96 ± 0.01** 
3 N/A N/A 18.22 ± 0.00 13.78 ± 0.03** 
 
 
3.3.5 Other studies confirming the specificity of blood and saliva specific markers. 
 A further three Taqman® studies were repeated for the same markers, the results 
again showing good specificity for most markers, the exceptions being HTN3 and SPTB 
(Figure 31) – the separate studies denoted by a number 1 or 2.  With regards to HTN3; firstly 
this marker was not detected in blood or saliva in the first study.  Secondly, in the last study 
the expression of HTN3 was lower in saliva than blood, a result that showed good specificity, 
Comparison of the ΔCt values for HTN3 in the blood sample in the last study compared with 
the HTN3 in the saliva sample in the second study shows that these values are very similar, 
which decreases the specificity of this marker slightly, in that you would not expect to see the 
same level of expression of a saliva marker in both blood and saliva.   
Analysis of the raw data however, demonstrated that in both blood samples that 
showed expression of HTN3, only two replicates showed amplification. All replicates were 
amplified for HTN3 in saliva and each exhibited a lower Ct value therefore supporting the 
specificity for saliva.   
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 SPTB was only detected in two studies in two different blood samples, and even then 
analysis of the raw data showed that amplification did not occur in all replicates.   This type 
of result is consistent throughout these Taqman® studies, where SPTB did not amplify in male 
blood; therefore the specificity of this marker seems good, but is not however always 
detectable in samples. 
 
 
Figure 30: qRT-PCR for blood and saliva-specific markers in blood and saliva stains.  Results are mean ± SEM, n =  3 
(except in cases where n <  3). Low ΔCt values correspond to a high expression level of the specific mRNA.   
 
3.3.6 Negative control amplification using Taqman® hydrolysis probes 
In SYBR® Green studies, where amplification was more often than not detected in the 
NTCs and the intercalating dye was non-specific, melt curve analysis was required and used 
to analyse the amplified product in the NTCs to confirm whether the amplification was 
specific.  In contrast however, no amplification was detected in the negative control samples 
in the Taqman® studies, thus demonstrating the advantages of using Taqman® hydrolysis 
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probes in comparison to SYBR Green, and also showing no contamination had occurred 
(Figures 31 - 34). 
 
Figure 31: Real-time PCR results for reverse transcription negative controls using Taqman® hydrolysis probes. 
 
 
Figure 32: Real-time PCR results for reverse transcription negative controls using SYBR® Green fluorescent dye 
 
 A comparison of the reverse transcription negative control amplification samples (RT 
NTCs) in both Taqman® and SYBR® Green studies was undertaken. 
Figure 31 shows a typical amplification plot for the RT NTCs in a Taqman® study, 
where zero amplification was observed.  In contrast, Figure 32 shows an amplification plot 
from a SYBR® Green study where all RT NTCs showed significant amplification, more than 
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likely due to the non-specific nature of the SYBR® Green fluorescent dye, which will bind to 
any ds-DNA.   
  
Figure 33: Real-time PCR results on negative control samples using Taqman fluorescent dye 
 
 
 
Figure 34: Real-time PCR results on negative control samples using SYBR Green fluorescent dye 
 
 A comparison of the negative control amplification samples (NTCs) in both Taqman® 
and SYBR® Green studies was also undertaken. 
Figure 33 shows a typical amplification plot for NTC samples in a Taqman® study, 
where zero amplification occurred.  Again in contrast, Figure 34 shows an amplification plot 
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from a SYBR Green® study, where some amplification was detected in the NTC samples, 
again demonstrating the non-specific nature of this type of chemistry 
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Chapter 4 
Discussion 
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4.1 Primer specificity using SYBR® Green  
The results from initial SYBR Green studies (three studies in total) revealed high 
specificity for blood-specific markers NCF2 and SPTB and saliva-specific marker KRT4.  All 
three of these markers were present in both blood and saliva samples.  NCF2 and SPTB were 
significantly under expressed in saliva signifying an over expression of these markers in 
blood.  KRT4 was significantly over expressed in saliva signifying an under expression in 
blood.  The specificity of these markers supports previous literature; markers NCF2 and 
KRT4 were reported to be highly specific and stable for use in forensic casework for the 
identification of blood and saliva, NCF2 being detected in 16 year old whole blood samples 
and KRT4 in 6 year old saliva stains (Zubakov et al., 2008, Zubakov et al., 2009).  SPTB has 
also been reported as a specific marker for blood in a number of studies, (Haas et al., 2009a, 
Juusola and Ballantyne, 2005, Ballantyne and Juusola, 2007b, Haas et al., 2008, Haas et al., 
2010, Haas et al., 2011a, Mindy et al., 2008, Haas et al., 2014, Patel and Peel, 2008).  Blood 
specific marker PBGD and saliva specific marker HTN3 however, were not detected in either 
blood or saliva in these initial studies.  This was an unexpected result given that previous 
literature reported good specificity for these markers.  It is worth noting that even though a 
positive result was obtained for KRT4 in one study, when investigated in a second repeat 
study, this marker was undetected in blood and saliva, thus questioning the suitability of this 
marker with regards to sensitivity as well as specificity.  NCF2 was also investigated in a 
second study, this marker was again detected in both blood and saliva samples and the result 
revealed an over expression in blood.   This over expression however in this instance could 
not be subjected to statistical analysis due to the fact NCF2 was only detected in one out of 
three replicates in the saliva samples.  Despite being able to statistically analyse this result, 
the NCF2 marker in this study again showed high specificity for blood, in that all three 
replicates in the blood samples showed expression for NCF2 in comparison to the saliva 
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sample that showed almost zero amplification.  In these initial studies, two out of three 
investigated the expression of saliva-specific STATH in blood and saliva, it was initially 
thought that this marker was detected in blood in one study and saliva in another; however the 
melt curve data for these results indicated clearly that this amplification was non-specific and 
most likely due to primer-dimer formation.  Thus, it can be said that in these studies, 
unexpectedly STATH was undetected in both blood and saliva samples, this result does not 
support previous literature which reported STATH to be a good mRNA marker for detection 
of saliva (Juusola and Ballantyne, 2003, Juusola and Ballantyne, 2005, Ballantyne and 
Juusola, 2007b). 
   Analysis of the ΔCt data confirmed the expression levels of the three markers that 
showed good specificity, in each case the blood specific markers NCF2 and SPTB exhibited 
lower ΔCt values in blood than in saliva, and the saliva specific marker KRT4 showed a 
lower value in saliva than in blood, a low ΔCt value indicates a higher expression of mRNA. 
 Interestingly, the melt curve data for saliva marker KRT4 in blood and saliva samples 
suggested that the amplification detected in the blood sample was due to non-specific 
amplification, and that the amplification observed in saliva was the result of targeting the 
sequence, thus revealing that KRT4 in this particular study was only detected in saliva, a 
positive result in terms of marker specificity.   For NCF2, the melt curve data suggested that 
specific amplification occurred in both blood and saliva.  Amplification of the targeted 
sequence in saliva was not a major cause for concern, since the expression levels observed in 
these studies revealed there was more NCF2 present in blood than in saliva.  Thus, this melt 
curve data supports the real-time PCR result with regards to marker specificity,  in that the as 
expected, NCF2 was detected in blood and at a much higher level than saliva.  In the case of 
SPTB, the melt curve data proved more difficult to determine, the melting peaks suggested 
the amplification in blood and saliva may have been specific, as two peaks were observed; a 
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main peak and a smaller hump to the left.  However, the peaks were not obviously separated 
like other melt curve data and the Tm of the main peak was quite low.  Thus casting doubt as 
to whether or not the amplification was a result of targeting the sequence or due to non-
specific amplification such as primer-dimer or low level contamination.   
 Amplification was detected in all 18s rRNA negative control samples (NTC) in these 
studies; this was expected given the ubiquitous nature of this reference gene and the non-
specific nature of SYBR Green dye.  This amplification also appeared to be specific 
according to the melt curve data however, the expression levels were very low according to 
the Ct values, and the melting peaks were of a much lower intensity in comparison to those 
observed for blood and saliva.  All other negative control samples were negative with the 
exception of KRT4 NTCs (in the study that showed detectable amplification for KRT4) and 
SPTB NTCs.  The melt curve data for KRT4 NTCs however suggested that this amplification 
was non-specific as the peaks exhibited typical primer dimer characteristics; in fact the peaks 
were almost identical to the peaks observed in the KRT4 blood sample.  Albeit it not ideal 
having amplification in the NTC sample, the fact that two distinguishable peaks were 
observed for the saliva sample and NTCs supports the result in that the amplification in saliva 
was most probably due to targeting the KRT4 sequence.  The melt curve data for SPTB NTCs 
suggested that the amplification observed in these samples was the same as the amplification 
observed in both blood and saliva, indicating that if the amplification observed in these 
samples were specific, then low level PCR product contamination may have occurred.  
Melting profiles are supportive and suggestive data used to increase the specificity of SYBR 
Green real-time PCR reactions, melting profiles on there own cannot be used as a sole way of 
validating the amplified products of a reaction, the negative control data and result of the real-
time PCR reaction must also be taken in to consideration for successful interpretation of a 
result.  As such, it can be said that in this particular study for SPTB, the data in its entirety is 
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suggestive that the correct amplified product may have been amplified however this could 
only be said with a low level of confidence due to the imperfect melt curves observed and the 
fact that the signals for the NTCs were not hugely different from the sample signals. 
 As the study progressed, further studies were performed to investigate the specificity 
of the specific markers mentioned above plus another two saliva-specific markers; KRT13 
and SPRR1A.  Again these markers were reported in the literature as stable and highly 
specific mRNA markers for the detection of saliva in body fluid identification tests in 
forensic casework (Zubakov et al., 2008, Zubakov et al., 2009).   In these later studies, the 
number of samples increased; both male and female samples were subjected to analysis for all 
markers.   
 There results were illustrated in five different expression plots for clarity.  In the first 
expression plot (Figure 9, Section 3.2.1), specific markers STATH and SPTB were 
investigated.  The results revealed a significant under expression of SPTB in all saliva 
samples compared to blood.  A positive result for the specificity of this marker as you would 
expect SPTB Under expression of STATH in all saliva samples also occurred compared with 
blood, this amplification later being confirmed by melt curve analysis to be non-specific, and 
as such it can be said that again this saliva-specific marker did not amplify in blood or saliva.   
Just as in previous studies, the melting profiles for SPTB could not confidently clarify 
whether or not the correct product had been amplified, this time only one peak was observed 
yet the Tm was still relatively low.  Amplification also occurred in the NTC for SPTB.  
However, in one of these studies even though the same Tm was observed for the NTCs and 
samples, the Ct values for were notably different, thus suggesting that if the amplification in 
these samples was due to targeting the SPTB gene then low level PCR product contamination 
may have occurred.  In this instance, if specific amplification has occurred, then the 
difference in these cycle numbers was big enough to be confident that the small amount of 
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product contamination was low enough to have little effect on the reliability of the sample 
signals.  However, this was not the case in the other study for SPTB where the melting peaks 
for NTCs were the same as the sample peaks and the Ct values were also relatively close.   
 In the second gene expression plot (Figure 11; Section 3.2.4), SPTB was investigated 
again along with a saliva-specific marker KRT13.  The results for SPTB again showed good 
specificity for blood in terms of the levels of expression observed in saliva samples compared 
to blood for both male and female samples, with the exception of one instance where SPTB 
was over expressed in a female saliva sample compared to male blood.  The melt curve data 
however, was again very similar to previous results for this marker and amplification was 
again detected in the NTCs, it was therefore hard to distinguish whether or not specific 
amplification of the target had occurred.  The expression levels between male and female 
samples also varied, in some cases more SPTB appeared to be present in male blood samples 
compared with female blood and vice-versa .  Indicating that expression of this marker varies 
between individuals.  The results for KRT13 revealed that in these studies, this marker 
showed very good specificity for saliva.  According the gene expression plot, KRT13 initially 
appeared to over expressed in a couple of blood samples compared to saliva, however 
analysis of the melt curve data indicated that this was not the case and that the amplification 
observed in these samples was non-specific.   The melting profile for KRT13 in saliva 
displayed typical characteristics for targeted sequence amplification; the peak was very 
distinctive to the blood sample peaks, being much larger in size and exhibiting a much higher 
Tm value.  This data therefore supports data shown in the expression plot and is strongly 
indicates that KRT13 in this particular study was specific to saliva.   
 Negative control amplification was observed in the KRT13 NTCs but the data showed 
almost identical results to the amplification observed in blood, suggesting this amplification 
was non-specific and most likely due to primer-dimer formation.  As expected, amplification 
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was again observed in all 18s NTC samples, in two out of three of these studies the 18s NTCs 
appeared to be specific just as in previous results, where the specific amplification was the 
result of very low levels of expression given the nature of the re gene and SYBR Green.   In 
the third study however, the melting profiles gave a more positive result for 18s NTC 
amplification, as the peaks for these particular samples exhibited a lower Tm value than the 
test samples, thus indicating the amplification in these negative controls was more than likely 
due to non-specific amplification.   
 In the third gene expression plot (Figure 15, Section 3.2.7) markers NCF2, KRT4, 
STATH and SPTB were investigated.  The results revealed good specificity for NCF2 and 
KRT4.  NCF2 was under expressed in saliva compared to blood in all cases and analysis of 
the melt curve data suggested this amplification was specific to targeting the NCF2 gene.  
KRT4 initially appeared to be over expressed in blood samples compared to saliva, however 
analysis of the melt curve data indicated that the amplification in blood for this marker was 
due to non-specific amplification, thus showing good specificity for this marker in saliva.  
SPTB was again under expressed in all saliva samples compared to blood, a positive result in 
terms of specificity, however the melt curve data showed a low Tm value like previous melt 
curves for this marker making it difficult to be confident that the amplified product was 
specific.  Saliva marker STATH showed expression data  in the gene expression plot, 
however melt curve analysis again suggested this amplification was due to primer-dimer 
formation rather than specific amplification, thus it can be said that STATH was undetected 
in both blood and saliva samples in this particular study.  
 Amplification was observed in the NTCs for all markers in these studies including 
18s NTCs.  The melt curve data clarified that the SPTB NTCs were due to specific 
amplification however, importantly the expression levels were much lower than the test 
samples.  The same was the case for NCF2 NTCs these result indicating that in these samples 
130 
 
low level PCR product contamination may have occurred.  The melting peaks for the 18s 
NTCs and KRT4 NTCs showed these samples to be due to non-specific amplification. 
In the fourth gene expression plot (Figure 19; Section 3.2.10), saliva specific markers 
HTN3, KRT4 and SPRR1A and blood marker NCF2 were investigated.  The results revealed 
that again NCF2 was under expressed in saliva, initially showing good specificity, however 
the melt curve data appeared to show that the main peak in the melting profile was down to 
amplification in the saliva sample rather than blood a result you would not expect given that 
NCF2 is blood specific.  . Also unexpectedly, KRT4 and HTN3 were under expressed in 
saliva; analysis of the entire data including the melt curve analysis demonstrated that the 
amplification observed for HTN3 was more than likely due to non-specific amplification 
indicating that this specific marker failed to amplify in all samples in these studies.  In 
contrast to previous results, KRT4 in this study did not show positive data with regards to 
specificity for saliva,, the over expression of this marker in blood coupled with the melt curve 
data made it difficult to conclude whether or not specific amplification had taken place in 
these samples.  Saliva specific marker SPRR1A however, gave a positive result in terms of 
specificity.  This marker was over expressed in all saliva samples and the melt curve data 
suggested this amplification was due to specific amplification.  Non-specific amplification 
was observed in the blood and NTCs for this marker, indicating these samples were the result 
of primer dimer formation, thus showing further specificity for this marker as it appears it 
was only detected in the saliva samples.  The NTC amplification observed for this marker 
was also extremely low indicating very low levels of PCR product contamination. 
Again all NTCs exhibited amplification in this study, some were a cause for concern 
as the demonstrated Ct values similar to test samples if not lower, with the exception of 
SPRR1A that showed the least level of expression in the NTCs.  The 18s NTCs again showed 
non-specific amplification. 
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In the fifth gene expression plot (Figure 21, Section 3.2.13), specific markers SPTB, 
KRT4, SPRR1A and NCF2 were investigated.   The results of this study revealed an over 
expression of SPTB and NCF2 in blood compared to saliva, and an over expression of 
SPRR1A and KRT4 in saliva than in blood, each of these markers showing good specificity 
for their respective body fluids.  The melt curve data for SPTB again showed similar results 
to previous studies, however amplification in the NTCs for this marker showed the NTC Ct 
values were slightly lower than the test samples, indicating that if the amplification was due 
to the targeted sequence then a slightly higher expression of product was observed in the 
NTCs.  The melt curve data for NCF2 marker suggested that the amplification observed in the 
blood and saliva samples was due to amplification of the targeted sequence.  This was a 
positive result for the specificity of this marker, as the expression levels were much higher in 
blood than saliva.  The melt curve data did however show that specific amplification occurred 
in the NTC sample for this marker, and that the Ct value was quite similar to the test samples 
thus questioning the reliability of this data.  Like the majority of previous studies, the melt 
curve data for KRT4 supported the real-time PCR expression data for this marker and showed 
good marker specific.  The amplification observed in the saliva samples appeared to be 
specific to KRT4, and the amplification observed in blood as well as the NTCs appeared to be 
non-specific amplification.  A result you would expect given that KRT4 is saliva specific, 
ideally you would expect to see no primer-dimer formation or non-specific amplification in 
the blood and NTC samples however, given the nature of the detection chemistry this appears 
unlikely.   Lastly, the melt curve data for SPRR1A was almost identical to the previous result; 
the data suggested specific amplification occurred in the saliva samples and non-specific 
amplification occurred in the blood and NTCs, indicating SPRR1A was only detected in 
saliva.   Again, NTC amplification varied in samples some showed very low levels of 
expression and some showed levels of expression on par with the test samples, which isn’t 
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ideal.  Amplification was detected in all 18s NTC samples again, like previous studies, and 
again this amplification appeared to be non-specific.  
Overall, the use of SYBR Green for the detection of these markers has proved quite 
challenging.   Specific markers PBGD and HTN3 were undetected using SYBR Green dye 
and amplification for the STATH marker proved in all cases to be non-specific.  For all other 
markers though  it appeared amplification in most cases was specific to the targeted sequence, 
however some of the results were left to open to interpretation due to the non-specific nature 
of the SYBR Green dye.  The most specific markers in these studies appeared to be NCF2, 
KRT4, KRT13 and SPRR1A showing reproducible results in a number of studies.  Blood 
marker SPTB also appeared to be specific to blood however, the melt curve data for this 
marker in each study was consistently questionable given the low melting temperatures for 
the amplified products.   It can therefore be said that real-time PCR using SYBR Green dye 
was capable of identifying mRNA specific markers in blood and saliva; however the 
specificity of these markers was not entirely reliable given the non-specific nature of SYBR 
Green.   
 
 
4.2 Comparison studies using TaqMan® assays 
 Following the SYBR Green studies a number of TaqMan® comparison studies were 
undertaken to assess the differences in primer detection and specificity using this detection 
chemistry.  The markers investigated in these studies were NCF2, STATH, HTN3, SPTB, 
KRT4 and KRT13.  Overall, NCF2 was consistently over expressed in blood compared to 
saliva, a positive result for NCF2 given that it is blood specific.  KRT4, KRT13, and STATH 
were also consistently detected in saliva and sometimes in blood, more often than not there 
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was zero amplification for these markers in blood.  HTN3 in most cases was detected in 
saliva than in blood, although on one occasion this marker was undetected in both blood and 
saliva.  The results for blood marker SPTB revealed that SPTB was detected in blood samples 
more than saliva however the detection in blood for this marker was still few and far between, 
i.e. SPTB was mainly detected in female samples compared with male and in some instances 
amplification was only based on one replicate out of three amplifying.     
 Overall, the mRNA markers of choice appeared to show better specificity using 
TaqMan Gene Expression Assays over SYBR Green.  For example, HTN3 showed no 
detectable amplification using SYBR Green, but was however detected in saliva on a number 
of occasions using TaqMan.  The results obtained for blood marker SPTB using TaqMan® 
were however not fantastic, and reflected the results for this marker in the SYBR Green 
studies, thus question the suitability of this marker.  STATH on the other hand showed very 
good specificity in these studies compared to SYBR Green where no detectable amplification 
was observed for this marker in any body fluid in any study.   
Analysis of the negative controls using TaqMan assays also proved to be much better 
than SYBR Green studies, this includes the reverse transcription negative control samples 
too.  
  The results of the SYBR Green studies vs. TaqMan highlights the disadvantages of 
using intercalating dyes rather than hydrolysis probe based detected chemistry for detection 
of specific mRNAs in body fluids.  The use of SYBR Green dye results in the amplification 
of non-specific PCR products which have demonstrated in this study to be quite problematic 
with regards to successful interpretation of the data.  The use of a dual-labelled probe 
however to identify a specific target sequence, results in the amplification of a specific target 
only, non specific amplification does not occur using TaqMan chemistry due to the specific 
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nature of the probe.  Thus, experiments using that latter chemistry are much less time 
consuming and require less validation that SYBR Green studies. 
4.3 18s Endogenous Control Amplification 
 It was noted that in all studies including both TaqMan and SYBR Green studies, the 
expression of 18s rRNA was consistently higher in saliva than in blood.   It is thought that 
this was due to amount of cells collected on a buccal swab during sample collection.  There 
are undoubtedly more cells collected on the swab during sample collection in comparison to 
cells from a fingreprick method when collecting blood, which would explain why there 
appears to be more 18s rRNA in saliva than blood as 18s is ubiquitous in nature. 
 
4.4. Summary 
  Originally, the aim of this study was to develop a more cost effective BFID test 
capable of distinguishing between blood and saliva, using SYBR Green fluorescent dye rather 
than TaqMan probe.  This was achieved by comparing the expression levels of specific 
mRNA markers for both blood and saliva.  The majority of markers demonstrated good 
specificity, however the reliability of the data was questionable on a number of occasions as 
low level contamination occurred in a number of samples.  Throughout this study, 
increasingly vigorous anti-contamination procedures were implemented to try to eliminate the 
possibility of contamination in these studies.  However, despite these attempts, the low-level 
amplification in the NTCs was never completely eliminated.  Specific amplification occurred 
in a number of NTC samples throughout the SYBR Green studies, thus decreasing the 
specificity and reliability of the result.  A vast amount of non-specific amplification also 
occurred, contributing to the on going challenge of interpretation.  
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 SYBR Green dye was originally chosen as it was thought to be more cost effective 
than TaqMan chemistry.  This is the case when purchasing reagents for a reaction, the primers 
are a lot cheaper than TaqMan probes, however one of the main disadvantages of using 
SYBR Green dye is that it will bind to any dsDNA, therefore the additional analyses required 
to validate and increase the specificity of the reaction due to the non-specific nature of this 
dye soon became quite costly.  With SYBR Green tests, more no template controls are 
required and the experiments were often repeated due to the issues of possible low level 
contamination in the NTCs. 
It can therefore be said that, SYBR Green dye utilising real-time PCR can be used to 
identify mRNA markers in blood and saliva, however TaqMan offers much greater sensitivity 
and specificity, and is less time consuming in terms of interpretation of the data (no post 
amplification analysis is required with hydrolysis probe based detection chemistry).  After 
these studies, it is thought that the use of SYBR Green dye in the long run appears not to be 
as cost effective as originally thought, due to the vast amount of validation controls required 
per experiment.  It is also a much more time consuming analysis compared with TaqMan 
chemistry.    
 
4.5 Further work 
 Further work would include the analysis of additional mRNA specific markers 
described in the literature, to see if any offer better specificity than those described and used 
in this study.  As well as blood and saliva, other forensically relevant body fluid markers 
would also be tested, such as vaginal secretions, menstrual blood and semen.  Repeat 
experiments would be performed to increase the reproducibility of the results in each study.   
Further studies in to primer concentration and optimisation would also be performed to 
136 
 
reduce or possibly eliminate the amount of primer-dimer formation; this would greatly 
increase the specificity of the reactions.  It is thought that if there was longer time to spend on 
this study then optimisation studies improving various experimental conditions could 
possibility result in a study that required less repeats and validation, thus bringing the cost 
down.  A study in to the use of different endogenous controls would also be used to see if 
there were a more suitable control, the ubiquitous nature of 18s rRNA resulted in a vast 
amount of NTC amplification.  Lastly, once a number of specific mRNA markers had been 
established and validated, future work could be carried out to assess the stability of these 
markers in body fluids over time, to assess whether or not body fluids of unknown age at a 
crime scene could be identified.  
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